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INTRODUCTION 
 
 Staphylococci are Gram-positive cocci that belong to the family 
Micrococcaceae.  They are the commonest of all clinical isolates and are 
responsible for several suppurative types of infections. They have a differential 
ability to spread and cause outbreaks in hospitals.1 However, due to development   
of methicillin resistance in Staphylococcus aureus isolates; treatment of these 
infections has become problematic. Indiscriminate use of multiple antibiotics, 
prolonged hospital stay, intravenous drug use, carriage of Methicillin resistant 
Staphylococcus aureus (MRSA) in nose are important risk factors for MRSA 
acquistion2    
 
Staphylococcus aureus produces a series of enzymes and toxins 5 and is a 
major pathogen causing skin abscess, wound infections, osteomyelitis, 
endocarditis, pneumonia, meningitis, bacteremia and toxic shock syndrome.3 
Originally, Penicillin was the drug of choice for treatment of serious 
Staphylococcus  aureus infections. The emergence of its resistance to penicillin 
was due to acquisition of a plasmid borne genetic element coding for beta 
lactamase production.  Semi synthetic, penicillinase resistant penicillins such as    
oxacillin and methicillin then became the drug of choice. Gradually, over the 
years, Staphylococcus aureus has evolved resistance to many antibiotics especially 
methicillin. Methicillin resistance first appeared   among nosocomial isolates of 
Staphylococcus aureus in 19616and resistance is due to the presence of altered 
penicillin –binding protein called PBP2a that results from acquisition of a 
chromosomal gene called mecA. The incidence of methicillin resistant 
Staphylococcus aureus (MRSA) in India ranges from 30 to 70%.8 Since MRSA’s 
are resistant to all β- lactam antibiotics, the therapeutic options are limited 
significantly. Moreover, the incidence of nosocomial infections caused by MRSA 
continues to increase world wide, and therefore   the importance of their detection, 
especially for therapeutic and epidemiological purposes arises.  Hence methods 
used to detect MRSA in clinical samples should have high sensitivity and 
specificity and most importantly the result should be available within a short time.  
There are many phenotypic methods available for detection of MRSA.  These 
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include Oxacillin and Cefoxitin resistance detection by   disc diffusion method, 
Oxacillin resistance agar screening, MIC of   > 4µg/ml to oxacillin, and Detection 
of PB2a by latex agglutination etc. Most laboratories detect MRSA by testing its 
susceptibility to Oxacillin 1µg by the Kirby Bauer disc diffusion technique. 
Problems in detection of MRSA have been reported with all the above methods, 
mainly due to the variability seen in the standard of techniques. Therefore, the 
Gold standard as of now, for the determination of MRSA, is by detection of MecA 
and Fem A gene by PCR. Traditionally MRSA has been considered as major 
nosocomial pathogen in health care facilities, but in the last decade it has been 
observed to be emerging in the community as well. The emergence of a community 
pathogen depends on its ability to survive in different environments and to interact 
successfully with the host. Staphylococcus aureus is one of the most successful 
and adaptable human pathogens.10 The community acquired strains tend to be more 
susceptible to non beta lactam agents as compared to hospital acquired MRSA 
isolates and appear to carry a unique staphylococcal chromosome (SCC mec type 
IV) in relation to resistant gene.7 MRSA’s are highly virulent strains capable of 
clonal dissemination and have the ability to cause epidemics of furunculosis and 
other skin and soft tissue infections, irrespective   of characteristics of populations 
or the setting. The community onset MRSA carrying the SCC mec type IV element 
possesses a serious threat and is likely to emerge as a major public health concern. 
The emergence of MRSA infections in the community places renewed emphasis on 
the importance of non-antibiotic management of localized infections. Although 
sometimes neglected, appropriate drainage is the definitive management of many 
skin and soft tissue infections and is always an important adjunct to antibiotic 
therapy in deeper, closed space infections. 
 
Coagulase negative staphylococci have long been regarded as harmless skin 
commensals and therefore were dismissed as contaminants. Their role as pathogens 
has been recognized only recently.  The increasing incidence of infections caused 
by this bacteria can be attributed to their particular affinity for foreign materials 
such as prosthetic valves, devices and intravascular catheters.9 Use of such 
invasive technologies   in patients who are sick, immunocompromised and at the 
extremes of age, has brought Coagulase negative Staphylococci to the forefront of 
nosocomial pathogens, resulting in considerable morbidity and spiraling medical 
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cost. Among the staphylococci, the two coagulase negative   species(CONS), 
Staphylococcus epidermidis and Staphylococcus saprophyticus, are seen frequently 
in human infections.3 Other staphylococci like Staphylococcus haemolyticus, 
Staphylococcus hominis, Staphylococcus simulans, Staphylococcus cohini etc 
although are found on human skin are sometimes implicated as the causative 
organisms in septicemia, osteomyelitis, catheter related sepsis and native valve 
endocarditis.4, 9       
              
          Methicillin resistant Coagulase negative staphylococci (MRCONS) have also 
emerged in hospitalized patients and patients who have undergone prosthetic heart 
valve surgeries.  Most infections due to CONS are nosocomial and it is not 
surprising therefore, that these infections have become increasingly resistant to 
multiple antibiotics. About 80-90% of CONS isolated from human specimens 
produce an inducible beta lactamase. Further- more 60-80% of nosocomial CONS 
are methicillin resistant. Methicillin resistant strains are often resistant to 
macrolides, lincosamides, aminoglycosides, fluroquinolones and other 
antimicrobial agents and emergence of strains with reduced susceptibility to 
glycopeptides has raised concern about development of strains resistant to all 
antibiotics.  
 
   Therefore recognition of isolates of Staphylococcus aureus as MRSA 
continues to be a task that clinical microbiologist should pursue diligently and 
report as accurately and as rapidly as possible. Renewed emphasis on the 
prevention of MRSA infections is also necessary. Control of MRSA in the health 
care setting remains an important means of limiting its spread in the community. 
 
                 This study aims at characterizing all Staphylococci including   
clinically relevant Coagulase negative staphylococci and comparison of   various 
methods used for detection of methicillin resistance and also includes the 
comparison of the antibiotic susceptibility pattern of CAMRSA v HAMRSA. 
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AIMS AND OBJECTIVES 
 
 
1. To isolate and identify Staphylococcal species from different clinical 
samples at PSG Hospitals, Coimbatore. 
2. To determine the incidence of Methicillin Resistant Staphylococcus aureus 
(MRSA) and compare between the phenotypic and genotypic methods for 
detection of MRSA. 
3. To compare the antibiotic susceptibility pattern between MSSA and MRSA, 
community acquired MRSA & hospital acquired MRSA and also to analyse 
the susceptibility pattern of Coagulase Negative Staphylococci 
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REVIEW OF LITERATURE 
 
        Staphylococci are gram-positive cocci belonging to family Micrococacceae. 
The term Micrococci is applied to a large variety of gram positive and mostly catalase 
positive cocci, some of which are saprophytes, widely distributed in nature, whereas 
others are parasitic and potentially pathogenic. They occur in pairs, small clusters and 
tetrads. The two genera Staphylococcus and Micrococcus are generally recognized and 
separated on the ability of staphylococcus to grow and produce acid from glucose 
anaerobically and its susceptibility to lysis by lysostaphin. Microcococci is negative for 
both the test. The international Sub committee on taxonomy of Staphylococci and 
micrococci has recommended adoption of standard method for distinguishing these 
organisms by anaerobic utilization of carbohydrates. Accordingly, if the standard test is 
used, those organisms which utilize glucose fermentatively (anaerobically) and are lysed 
by 1μ/ml lysostaphin endopeptidase are designated as Staphylococcus and those that do 
not produce acid   from glucose or do so oxidatively (aerobically) only are designated as 
Micrococcus. Bergy’s manual includes additionally the genus Planococcus in the 
Micrococcaceae and the genera Aerococcus, Pediococcus and Leuconostoc in the family 
Streptococcaceae where as the International subcommittee on the nomenclature of 
staphylococci and Micrococci places Aerococcus in the Micrococcaceae. Planococcus 
and Leuconostoc do not cause human infections.11  
History  
In 1871,Von Reckling Hausen first observed Staphylococci in pus. It was 
cultivated on liquid media by Louis Pasteur (1880) and was shown by Alexander 
Ogston, a Scottish surgeon in the year 1881, to be frequently associated with acute 
and chronic diseases. He also gave it the name Staphylococcus.  Ogston also 
noticed that non- virulent Staphylococci were also present on the skin surface. 
Rossenbach in 1884 made a detailed study, obtained them in pure culture and 
divided them into two species   Staphylococcus aureus and Staphylococcus albus 
Passet in the year 1885 added another species Staphylococcus citreus.  
Welch later named staphylococcus albus as Staphylococcus epidermidis in the year 
1891.  This distinction was of considerable importance, since Staphylococcus 
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aureus was a major cause of mortality and morbidity   and clinical specimens often 
carried both type of organisms. Von daranyi in year 1925 was the first person to 
draw attention to the partial   value of the coagulase test to identify Staphylococcus 
aureus, and it still remains the most important test   used in clinical laboratory to 
identify this species. Until 1975 Coagulase Negative Staphylococci were grouped 
together as Staphylococcus epidermidis, distinguished by their inability to clot 
blood plasma. In 1975, Kloos Schleiferi extended the existing identification 
scheme by adding seven new species   to the already known Staphylococcus 
epidermidis and Staphylococcus saprophyticus. Today there are about 32 species 
of CONS and about 15 of them are indigenous to man while the remaining are non-
human pathogens. During the past few decades, importance of CONS as a human 
pathogen is being recognized. In year 1994-1995, the national nosocomial 
infection surveillance program reported that CONS were the causative agent in 
11% of all nosocomial infection, making this pathogen the third most common 
nosocomial isolate.  CONS equal or surpass Staphylococcus aureus   as a cause of 
device related   nosocomial infection. Staphylococcus epidermidis is a common 
member of the normal flora of skin and mucous membranes. Its large numbers and 
ubiquitous distribution make it one of the most commonly isolated organisms in 
the clinical laboratory. While at one time the appearance of Staphylococcus 
epidermidis in clinical material could be dismissed as contamination, it is now one 
of the most important agents of hospital acquired infections. Coagulase negative 
staphylococci, notably   Staphylococcus epidermidis may produce slime which 
envelops cells and aids their adherence to and accumulation   on the surfaces of 
medical devices such as catheters and prosthesis.3Immunosuppressed or 
neutropenic patients are particularly at risk, as are individuals with indwelling 
catheters or prosthetic devices. It can also cause endocarditis in individuals with 
previous heart valve damage. The hydrophobic nature of the organism's cell 
surface facilitates its adherence to synthetic devices as well as damaged heart 
valves. Following initial colonization, a copious amount of extra cellular 
polysaccharide or slime is synthesized, forming a protective biofilm around the 
colony. Because many isolates are multiple antibiotic resistant, these infections are 
very serious and can even be fatal. 
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  In a series of clinical observations and laboratory studies published in 1880 
and 1882, Ogston described staphylococcal disease and its role in sepsis and 
abscess formation. More than 100 years later, Staphylococcus aureus still remains 
a versatile and dangerous pathogen in man. The frequencies of both community-
acquired and hospital-acquired staphylococcal infections have increased steadily, 
with little change in overall mortality. Treatment of these infections has become 
more difficult because of the emergence of multi drug-resistant strains.  
 
Morphology 
 
Staphylococci are spherical organisms with a diameter of 0.8-1µm in size. In films 
of pus or solid media, they appear as grape like cluster with a few single and paired 
Cocci, whereas in broths they appear as small groups, pairs, singles and short chains (less 
than five cocci in line). They are Gram Positive, nonsporing, nonmotile and except for 
strains, which have a microcapsule, most are noncapsulate3, 4,5,11. Of the 11 types of 
micro capsular polysaccharide serotypes that have been identified, types 5 and 8 
account for 75 percent of human infections. Most methicillin-resistant 
Staphylococcus aureus isolates are type 5. The chemical composition of four of 
these antiphagocytic polysaccharides, including types 5 and 8, has been 
determined, and all four have been shown to be chemically related. 16 Differences 
in the peptidoglycan structure of staphylococcal strains may contribute to 
variations in their capacity to cause disseminated intravascular coagulation. 
Peptidoglycan may have endotoxin-like activity, stimulating the release of 
cytokines by macrophages, activation of complement, and aggregation of platelets. 
Ribitol teichoic acids, covalently bound to peptidoglycan, are major constituents of 
the cell wall. Lipoteichoic acid is a glycerol phosphate polymer linked to the 
glycolipid terminus anchored in the cytoplasmic membrane. 16 
Surface Proteins  
 A ligand-binding domain at the N terminal of secretory signal sequence 
that is exposed on the surface of the bacterial cell enables some of these proteins to 
function as adhesins. Protein A, the prototype of these proteins, has antiphagocytic 
properties that are based on its ability to bind to the Fc portion of 
immunoglobulins.  
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Several of these related proteins bind extra cellular-matrix molecules and 
have been designated microbial-surface components recognizing adhesive matrix 
molecules (MSCRAMM). Recent studies suggest that these proteins play an 
important part in the ability of staphylococci to colonize host tissue.  
Cultural Characteristics 
 
Staphylococci grow well on blood free basal media. They are facultative 
anaerobes having an optimum ph between 7.4-7.6 and temperature between  35-
37ºC.They are also able to grow between 12-44 ºC. After aerobic incubation on nutrient 
agar for 24 hours, the colonies are 2-3mm in diameter, have a smooth glistening surface, 
entire edge, butyrous consistency and   opaque, pigmented appearance. Colonies are 
smaller and pigmentation is absent on plates incubated anaerobically .3,4,5,11 
 
Pigmentation 
 
Golden (orange, yellow and cream   to buff varieties), white or may be poorly 
developed in 24 hours. It is enhanced by prolongation of incubation for 48 hours or   
incubation at room temperature or by use of pigment enhancing medium such as milk 
agar (33%full fresh milk), cream agar (10% cream) or glycerol monoacetate (1%) 
spreading   a colony  on white filter paper and allowing it to dry is simple and satisfactory 
a way of detecting pigment .The yellow pigments which are triterpenoid carotenoids are 
located in the cellmembrane3. Many strains   are beta hemolytic on blood agar. Sheep’s 
blood is recommended   because sheep’s   RBC are lysed by alpha toxin which is 
considered to be most important staphylococcal   toxin, whereas human RBC are lysed by 
delta toxin. Macconkey agar-Colonies are pinkish (lactose fermenting) and very small to 
normal in size depending on the batch of the medium Broths: Uniform turbidity is seen 
with some powdery deposit.3,4,5 
 
Morphology variants 
 
          Prolonged incubation particularly important to detect morphology variants such as 
small colony variants  (SCV). SCV’s grow into tiny colonies that are difficult to 
distinguish.  They result from mutations in the respiratory chain and possibly other kinds 
of mutations that are yet to be known. SCV’s are more tolerant to killing by a number of 
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additional antibiotics like aminoglycosides, beta lactams and glycopeptides. SCV’s are 
infective as or more than other fast growing ones.3, 11 
 
Selective media11  
Salt Media 
a) Columbia agar with added salt 
b) Muller Hinton agar with 2% salt 
c) Mannitol salt agar 
This medium is used in addition to blood agar when contamination with other 
bacteria is expected because high content of sodium chloride (7.5%) and presence 
of mannitol and phenol red in this medium, Staphylococcus aureus will appears 
yellow colony surrounded by yellow zone where as other Staphylococci usually 
form a small colony in red or purple zone and other organisms including gram 
negative organisms are usually completely inhibited. So manitol salt agar is an 
indicator medium also  
d) Staphylococcus medium no110 and Chapman stone agar 
These high salt content media containing mannitol and gelatin are now used less 
frequently than before since gelatin liquefaction is no longer considered a 
differential test in classification.   
e) Tojel Johnson medium supplemented with 0.5% pyruvate and salt milk 
agar 
 
Tellurite containing media 
 
a)  Baird Parker agar containing potassium tellurite and lithium chloride as 
selective agents. 
b)  Tellurite glycine agar:  It is a medium containing glycine, lithium chloride and 
potassium tellurite as selective agents.  Coagulase positive Staphylococci produce 
black colonies where as Coagulase negative Staphylococci or other organisms fail 
to produce visible growth in 24 hrs or form grey colonies.   
 
Mannitol Neomycin agar 
 
 This consist of trypticase soy agar (1 lr) mannitol (10g) Neomycin sulphite 
(0.0005g) phenol red (0.0025g) and defribrinated sheep’s blood (50 ml).  This medium is 
 10
used for isolation and identification of Staphylococci.  This medium inhibits Coagulase 
Negative Staphylococci and micrococci but not Coagulase positive Staphylococci, 
Streptococcus, Proteus, Pseudomonas and Candida.  
 
Indicator media3,4,11 
Phenophathalein diphosphate agar  
This indicator media allows provisional identification of colonies of 
Staphylococcus aureus in mixed cultures.   Few colonies of CONS like Staphylococcus 
epidermidis are also phosphatase positive. 
Toxins and Enzymes 
Staphylococci produce numerous toxins that are grouped on the basis of their 
mechanisms of action. Cytotoxin, such as the 33-kd protein-alpha toxin, cause pore 
formation and induce proinflammatory changes in mammalian cells. The 
consequent cellular damage may contribute to manifestations of the sepsis 
syndrome. The pyrogenic-toxin super antigens are structurally related, sharing 
various degrees of amino acid sequence homology. They function as super antigens 
by binding to major Histocompatability complex (MHC) class II proteins, causing 
extensive T-cell proliferation and cytokine release. Different domains of the 
enterotoxin molecule are responsible for the two diseases caused by these proteins, 
the toxic shock syndrome and food poisoning. Despite little amino acid sequence 
homology, toxic shock syndrome toxin 1 is structurally similar to enterotoxin B 
and C. The gene for toxic shock syndrome toxin 1 is found in 20 percent of 
Staphylococcus aureus isolates. The exfoliate toxins, including epidermolytic 
toxins A and B, causes skin erythema and separation, as is seen in the 
staphylococcal scalded skin syndrome. The mechanism of action of these toxins 
remains controversial. Panton–Valentine leukocidin is a leukocytolytic toxin that 
has been epidemiological associated with severe cutaneous infections. 
Staphylococci produce various enzymes such as protease, lipase and hyaluronidase 
that destroy tissue. These bacterial products may facilitate the spread of infection 
to adjoining tissues, although their role in the pathogenesis of disease is not well 
defined.16 From 1945 onwards, Penicillin destroying enzymes were encountered, 
first in strains isolated in hospitals, then those from general population. Four types 
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of Staphylococcal penicillinase have been described.All types are inducible and 
extra cellular. 
Genome  
The Staphylococcal genome consists of a circular chromosome (of 
approximately 2800 bp), with prophages, plasmids, and transposons. Genes 
governing virulence and resistance to antibiotics are found on the chromosome, as 
well as the extra chromosomal elements. These genes are transferred between 
staphylococcal strains, species, or other gram-positive bacterial species through 
the extra chromosomal elements.16 Methicillin-resistant Staphylococcus aureus 
(MRSA) strains possess the mecA gene, which is carried by a unique mobile genetic 
element, Staphylococcal cassette chromosome (SCCmec), integrated into the 
Staphylococcus aureus chromosome, SCC, whose integration into and excision from the 
Staphylococcus aureus chromosome are mediated by a unique set of recombinase genes, 
ccrA and ccrB.  A full characterization of MRSA strains requires structure determination 
of the complex SCCmec element. In addition to the SCCmec types I–V, several subtypes 
have been isolated. 108,110 
Genetic Regulation of Virulence-Determinant Expression  
Global regulatory genes that coordinate the expression of various groups of 
staphylococcal genes have been identified. The most extensively studied gene, agr, 
induces the expression of exoprotein (extra cellular protein) while suppressing the 
expression of surface protein through a bacterial-density–sensing octapeptide. 
Surface proteins are predominantly synthesized during the exponential growth 
phase, and the secreted proteins are synthesized during the stationary phase. This 
sequential expression of genes may have clinical importance. Different stages of 
staphylococcal infection appear to require different panels of virulence 
determinants. During the initial stages of infection, the expression of surface 
proteins that bind extra cellular-matrix molecules favors successful colonization of 
host tissues, whereas the synthesis of exoproteins favors the spread to adjacent 
tissues. This hypothesis is supported by studies in animals showing that the 
inactivation of regulatory genes reduces bacterial virulence16 
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Epidemiology of Staphylococcal Disease  
Colonization and Infection  
Human beings are a natural reservoir of Staphylococcus aureus. Thirty to 
fifty percent of healthy adults are colonized, with 10 to 20 percent persistently 
colonized. 17,18 60% intermittent carriers and 20% non carriers. Both methicillin-
sensitive and methicillin-resistant isolates are persistent colonizers and most often 
involves anterior nares and is frequently asymptomatic. Persons colonized with 
Staphylococcus aureus are at increased risk for subsequent infections. Rates of 
such colonization is high among patients with type 1 diabetes, intravenous drug 
users, 19 patients undergoing hemodialysis,20 surgical patients and patients with the 
acquired immunodeficiency syndrome. Patients with qualitative or quantitative 
defects in leukocyte function are also at increased risk for staphylococcal disease. 
MRSA colonization is particularly important in hospital environment.22 
Pathogenesis of staphylococcal disease 
Transmission  
Persons colonized with Staphylococcus aureus strains are at increased risk 
of becoming infected with these strains. Most cases of nosocomial infection are 
acquired through exposure to the hands of health care workers after they have been 
transiently colonized with staphylococci from their own reservoir or from contact 
with an infected patient. Outbreaks may also result from exposure to a single long-
term carrier or environmental sources, but these modes of transmission are less 
common. Air borne transmission may rarely occur in MRSA positive cases with 
upper respiratory tract infections.21   One in five chance that a patient harbouring 
MRSA at admission can go on to develop an infection if not identified and  
treated.45 
Temporal Trends in Staphylococcus aureus Disease  
The numbers of both community-acquired and hospital-acquired 
staphylococcal infections have increased in the past 20 years. This trend parallels 
the increased use of intravascular devices. During the period from 1990 through 
1992, Staphylococcus aureus was the most common cause of nosocomial cases of 
 13
pneumonia and surgical-wound infections and the second most common cause 
(after coagulase-negative staphylococci) of nosocomial bloodstream infections, 
according to data from the National Nosocomial Infections Surveillance system of 
the Centers for Disease Control and Prevention (CDC) 16.  
A second trend, resulting in part from selective antibiotic pressure, has been 
the dramatic worldwide increase in the proportion of infections caused by 
methicillin-resistant Staphylococcus aureus. Initially noted in tertiary care 
hospitals, methicillin-resistant strains are increasingly found in the community. 
Data from the National Nosocomial Infections Surveillance system for the period 
from 1987 to 1997 show that the number of methicillin-resistant Staphylococcus 
aureus infections in intensive care units has continued to increase. Methicillin-
resistant strains have also become resistant to other antimicrobial agents.  
Staphylococcus aureus has a diverse arsenal of components and products 
that contribute to the pathogenesis of infection. These components and products 
have overlapping roles and can act either in concert or alone. A great deal is 
known about the contribution of these bacterial factors to the development of 
infection. Considerably less is known about their interaction with each other and 
with host factors and their relative importance in infection.  
The virulence of Staphylococcus aureus infection is remarkable, given that 
the organism is a commensal that colonizes the nares, axillae, vagina, pharynx, or 
damaged skin surfaces. Infections are initiated when a breach of the skin or 
mucosal barrier allows staphylococci access to adjoining tissues or the 
bloodstream. Whether an infection is contained or spreads depends on a complex 
interplay between Staphylococcus aureus virulence determinants and host defense 
mechanisms.  
The biology of colonization of the nares, the primary reservoir for 
staphylococci, is incompletely understood. Mucous membrane appears to be the 
critical host surface that is colonized in a process involving interactions between 
staphylococcal protein and mucin carbohydrate. The role of other commensals, 
secretory IgA, or specific staphylococcal adhesins is unknown.  
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The risk of infection is increased by the presence of foreign material. Elek 
and Conen, first demonstrated the ability of sutures to reduce the threshold for 
infection. Several factors contribute to the increased susceptibility to infection. 
Phagocytic function in the presence of foreign material in seriously impaired. 
Devices such as intravenous catheters are rapidly coated with serum constituents, 
such as fibrinogen or fibronectin, which enable staphylococci to adhere through 
MSCRAMM-mediated mechanisms and to elaborate glycocalices that further 
facilitate colonization. Intravenous catheters are frequently implicated in the 
pathogenesis of nosocomial endocarditis. The introduction of long-term indwelling 
catheters has led to cases of nosocomial endocarditis that resemble the animal 
model of endocarditis. The catheter traumatizes the valvular surface, creating a 
nonbacterial thrombus on the cardiac valve that facilitates subsequent bacterial 
adherence.16 
Invasive Infections  
Endocarditis, metastatic infection, or the sepsis syndrome may complicate 
Staphylococcal bacteremia. The endothelial cell is central to these pathogenic 
processes. Not only is it a potential target for injury, but also its activation 
contributes to the progression of endovascular disease. Staphylococci avidly 
adhere to endothelial cells and bind through adhesion–receptor interactions. In 
vitro studies demonstrate that after adherence, endothelial cells phagocytose 
staphylococci.  
The intracellular environment protects staphylococci from host defense 
mechanisms as well as the bactericidal effects of antibiotics. Vesga et al 
demonstrated that the intraendothelial-cell milieu fosters the formation of small-
colony variants. These factors may enhance bacterial survival and contribute to the 
development of persistent or recurrent infections. Staphylococcal strains that cause 
endocarditis adhere to both damaged and undamaged native valvular surfaces, are 
resistant to platelet microbicidal proteins, 23and elaborate proteolytic enzymes that 
facilitate spread to adjacent tissues. The adherence of staphylococci to the 
platelet–fibrin thrombus that forms on damaged valvular surfaces may involve the 
adherence of MSCRAMM proteins to exposed matrix molecules. Staphylococcal 
endocarditis also occurs on undamaged valves. The invasion of endothelial cells by 
 15
Staphylococcus aureus may initiate the cellular alterations, including the 
expression of tissue factor, that promote the formation of vegetations 
Toxin-Mediated Disease  
Pyrogenic-toxin superantigens cause life-threatening disease that is 
characterized by the rapid onset of high fever, shock, capillary leak, and 
multiorgan dysfunction. Super antigens are T-cell mitogens that bind directly to 
invariant regions of MHC class II molecules, bypassing intracellular protein 
ingestion and digestion and subsequent peptide presentation by antigen-presenting 
cells. The MHC-bound super antigens then attach to T cells according to the 
composition of the variable region of the T-cell–receptor chain. Toxic shock 
syndrome toxin 1 binds all variable-region 2–positive T cells, causing an 
expansion of Clonal T cells (5 to 20 percent of resting T cells as compared with 
0.01 percent of T cells for processed antigens), resulting in the massive release of 
cytokines by both macrophages and T cells. These cytokines mediate the toxic 
shock syndrome, whose pathophysiology mimics that of Endotoxic shock. In both 
syndromes, bacterial products induce the release of excessive quantities of 
cytokines, which then cause tissue damage.16 
 Host Response to Infection  
The typical pathological finding of staphylococcal disease is abscess 
formation. Leukocytes are the primary host defense against Staphylococcus aureus 
infection. The migration of leukocytes to the site of infection results from the 
orchestrated expression of adhesion molecules on endothelial cells. This cytokine-
mediated process is triggered by bacteria and tissue-based macrophages. After 
infection, cytokines are first demonstrable within vessels, extending into the 
tissues, as inflammatory cells migrate to the sites of infection.  Staphylococcus 
aureus infected endothelial cells also express intercellular adhesion molecule 1 
(CD54), vascular-cell adhesion molecule 1 (CD106), and MHC class I molecules 
and probably contribute to this process. 24Genetically manipulated mice lacking 
intercellular adhesion molecule1 have a defect in leukocyte migration that results 
in increased mortality, but they also have less severe staphylococcal infections 
than normal mice, perhaps as a result of decreased leukocyte-mediated damage.25  
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The presence of opsonizing antibody directed against capsule, 
peptidoglycan, or complement facilitates Phagocytosis in vitro. The role of 
antibody in vivo is less certain, since the titer of antistaphylococcal antibodies is 
not correlated with protection from infection, except in the case of toxic shock 
syndrome, in which the presence of anti–toxic shock syndrome toxin 1 is 
protective. At present, it is not known which staphylococcal components are 
capable of inducing protection from subsequent infection.  
Diseases Caused by Staphylococcus aureus  
Staphylococcus aureus infection is a major cause of skin, soft-tissue, 
respiratory, bone, joint, and endovascular disorders. The majority of these 
infections occur in persons with multiple risk factors for infection. Staphylococcus 
aureus causes a variety of skin infections ranging from superficial skin infections 
to severe, toxin mediated systemic infections. Staphylococcus aureus   produces 
many extracellular products, including toxins that affect host cell function or 
morphology42 
Folliculitis 
Follicultis is a benign infection restricted to the ostia of the hair follicles 
and is characterized by the presence of small reddish painful lesions 3, 5  
Furuncles &Carbuncle 
Furuncles are deep-seated   pyodermas that are present as painful firm, 
raised lesions with necrotic centers containing purulent material. Carbuncles refer 
to even more deep-seated lesions that involve the subcutaneous   tissues. Several 
lesions may be present and may coalescence via formation of subcutaneous tracts. 
Carbuncles are often associated with systemic signs of chills and fever.3, 5 
Impetigo 
It is a superficial staphylococcus infection that is seen mostly in children 
and usually present on exposed areas especially on the face. Impetigo begins as red 
macules that evolve into vesicles containing serosanguinous   fluid. The lesions 
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eventually rupture becomes dry and crusted with honey coloured scab on an 
erythematous margin. Staphylococcus aureus accounts for 80-90% of cases and 
rest contributed by Group A Streptococcus 3, 5 
Cellulites and Erysipelas 
Cellulites and erysipelas are terms for diffuse, spreading skin infections 
without underlying purulence or necrosis (tissue death). The terms are often used 
interchangeably but, classically, erysipelas is defined by the fact that the lesion is 
raised above the level of the surrounding skin and that there is a clear line of 
demarcation between involved and uninvolved tissue. Cellulites, on the other hand, 
are not so clearly demarcated and tend to involve the deeper skin tissues and 
subcutaneous fat. Both may also be associated with lymphangitis (inflammation of 
the lymph vessels manifest by "streaking" erythema, or redness, extending from 
the lesion) and swelling of regional lymph nodes. Often, the skin can take on a 
brawny, wooden texture. Superficial blisters may develop, as well. Systemic 
symptoms, such as fever, rapid heart rate, and low blood pressure, can often 
accompany erysipelas or cellulites and are signs of serious illness that requires 
prompt evaluation and treatment with systemic antibiotics. In less than 5% of all 
cases, the infecting organism can be isolated from the blood stream.3, 5, 16 
Staphylococcus scalded skin syndrome  
Staphylococcal toxic shock syndrome (STSS) and staphylococcal scalded 
skin syndrome (SSSS) are 2 distinct toxin mediated diseases with very distinct 
cutaneous features. STSS was first described in 1978 and TSST-1 and enterotoxins 
are associated with it .88 Staphylococcal Scalded Skin Syndrome was produced by 
exfoliative toxins A and B which were first described in   1975    .In this, bullous 
formations occur over large areas of the body with subsequent sloughing of the 
superficial   skin layers. This result in the exposure of large areas of denuded and 
raw skin .The disease is usually seen in neonates and infants. Staphylococcus 
aureus is not present in the skn lesions but is confined to the primary site of 
infection, usually the nasopharynx.63  
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Staphylococcal toxic shock syndrome came to prominence in 1980–1981, 
when numerous cases were associated with the introduction of super absorbent 
tampons for use during menstruation. The disease is characterized by a fulminating 
onset, often in previously healthy persons. The diagnosis is based on clinical 
findings that include high fever, erythematous rash with subsequent desquamation, 
hypotension, and multiorgan damage. Alternative diagnoses, including Rocky 
Mountain spotted fever, streptococcal scarlet fever, and Leptospirosis, must be 
ruled out. The toxic shock syndrome often develops from a site of colonization 
rather than infection. Although toxic shock syndrome toxin 1 accounts for more 
than 90 percent of cases of the syndrome that are associated with tampons, other 
enterotoxin account for 50 percent of cases unrelated to menstruation. Such cases 
have increased in the recent past, accounting for approximately one third of all 
cases and are associated with localized infections, surgery, or insect bites.16  
 
Surgical Site Infections (SSI) 
 
Surgical site infections (SSI) account for 12.3%-24% of hospital acquired 
infections. Overall Staphylococcus aureus is the dominant species in SSI followed 
by enterobacteria. 29 UK surveillance data shows that approximately two thirds of 
staphylococcus SSI is caused by MRSA. Even higher MRSA prevalence   is seen in 
subspecialties such as vascular surgeries. In great majority of cases, the origin of 
bacteria appears to be patients own body flora. Few more studies also reported   
that maximum number of MRSA were recovered from post operative   surgical site   
infections.28, 29,61   Infections of surgical wounds are the most common adverse 
events in patients who are hospitalized and have undergone surgery, accounting for 
38% of all hospital-acquired infections in surgical patients Superficial incisional 
infections do not extend below the subcutaneous space and are notable for purulent 
drainage from the incision, pain, tenderness, swelling, and redness. They typically 
occur within 30 days of the initial surgery. A deep incisional infection extends into 
the underlying fascia and muscle. It presents in a similar fashion as the superficial 
incisional infection and also typically arises within 30 days of initial surgery. 
However, if prosthesis was inserted, deep incisional infections can occur up to a 
year after initial surgery. Any deep incisional infection that does not resolve as 
expected raises the possibility that, in fact, the incisional infection may just be a 
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superficial manifestation of a deeper organ/space infection. The most common 
organism is staphylococcus (20%) and incidence of MRSA among surgical site 
infections (SSI) is increasing.29            
        
               Factors most consistently associated with increased incidence of post operative 
infections are   over 60 years of age, pre- operative stay in hospital, long duration of 
surgical procedure,    pre-existing infection at site of the wound. Other equally important 
condition that plays an important role are diabetics, immune suppression, irradiation, mal-
nutrition. More recently the extensive use of   indwelling   medical    devices   and 
possibly as a result of introduction of new antibiotic, coupled with their indiscriminate 
use ,these staphylococci has now emerged  as the most predominant pathogen. 
 
Diabetic wound infections  
 
In particular, methicillin-resistant Staphylococcus aureus (MRSA) 
pathogens have been isolated with increasing frequency (30-50%) from wound and 
skin infections that commonly affect the lower extremities of patients with 
diabetes. 25,105For these individuals, foot infections caused by MRSA organisms 
have been associated with poorer outcomes related to an increased risk of 
amputations and infection-related mortality.   
 
Burns 
 
Burns provide a suitable site for bacterial multiplication. The clinical 
consequence   of infection in burns may be serious, a large proportion of mortality 
in burned patients who survived the initial trauma and shock has been due to 
infection. Staphylococcus aureus and Pseudomonas aeroginosa are the most 
common isolates in most burn units. In a study, the incidence of Staphylococcus 
aureus was 41.8%, out of it, 51.6% were MRSA.1 As in other hospital areas, the 
emergence of resistant gram positive bacteria including MRSA has been seen in 
burn units.30, 31, 33, 34          
Osteomyelitis/Septic arthritis 
Staphylococcus aureus osteomyelitis most often occurs as a complication of 
local infection via direct extension although haematogenous osteomyelitis may 
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also occur. Staphylococcus aureus constitutes to 50-70% of all Osteomyelitis 
cases. Haematogenous osteomyelitis   usually involves long bones in children, but 
osteomyelitis of vertebral column accounts for 60% of such infection in adults. 
Abscess and Lytic bone lesion must be aspirated and cultured to provide definitive 
diagnosis.3, 5   
Sepsis  
 
A minority of bacteremic or local infections progress to sepsis. Risk factors 
for sepsis include advanced age, immunosuppression, chemotherapy, and invasive 
procedures. The presentation of staphylococcal sepsis is similar to that of gram-
negative sepsis, with fever, hypotension, tachycardia, and tachypnea. 
Staphylococcus aureus is one of the most common gram-positive pathogens in 
cases of sepsis. Severe cases progress to multi-organ dysfunction disseminated 
intravascular coagulation, lactic acidosis, and death. In sepsis, the levels of 
circulating tumor necrosis factor, interleukin-1, and interleukin-6 are predictive of 
the outcome. 16 Staphylococcus aureus is a much less common cause of neonatal sepsis 
in recent decades than its peak incidence in 1950s through 1970s.103 An overall 
predominance of Gram negative bacteria is seen in these cases nowadays.104 Localized 
infections have a tendency   to spread to surrounding tissues or frequently via 
blood stream to distant sites. Staphylococcus aureus is commonly isolated from 
patients with both community acquired and nosocomial infections. They are the 
second most common cause of nosocomial blood stream infection accounting for 
20% of the infections. Incidence varies from 10% in patients under age of one year 
to 24% in patients over age of 65 years. Staphylococcus Aureus infection 
originates from localized infection, an intravascular catheter or contaminated 
syringe. The overall rate of mortality from Staphylococcal bacteremia, which has 
not changed in the past 15 years, ranges from 11 to 43 percent. Factors associated 
with increased mortality include an age of more than 50 years, irremovable foci of 
infection, and serious underlying cardiac, neurological, or respiratory disease. 
Bacteremia caused by methicillin-resistant strains is associated with increased 
mortality. The change in the Acute Physiology and Chronic Health Evaluation 
(APACHE II) score from the day before to the day of Staphylococcus aureus 
bacteremia was recently found to predict the clinical course and outcome. The 
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frequency of complications due to Staphylococcal bacteremia is high, ranging from 
11 to 53 percent. As  many as 31 percent of patients with bacteremia who do not 
have evidence of endocarditis, presented with metastatic infection. An increasing 
percentage of bacteremia infections are related to catheterization. The rate of 
complications is lower for catheter-related infections than for all cases of 
bacteremia (24 percent), as is the overall mortality rate (15 percent). Patients with 
bacteremia or fever that persists for more than 72 hours after the catheter has been 
removed may have an increased risk of complications.46 The incidence of 
endocarditis in patients with catheters, estimated on the basis of clinical indicators, 
is also low, ranging from 0 to 18 percent. Some studies, however, suggest that the 
incidence of endocarditis may be higher. Espersen and Frimodt-Møller reported 
that the diagnosis of Staphylococcus aureus endocarditis was made at autopsy and 
not suspected clinically in 55 percent of the patients in their series (65 of 119). 26 
Using transesophageal echocardiography, Fowler et al. recently found that 25 
percent of selected patients with staphylococcal bacteremia (26 of 103) and 23 
percent of those with catheters as the primary focus (16 of 69) had transesophageal 
echocardiography evidence of endocarditis in the absence of clinical or 
transthoracic echocardiography findings.27 
Endocarditis  
The incidence of Staphylococcus aureus endocarditis has increased and now 
accounts for 25 to 35 percent of cases.16 It occurs in intravenous drug users, 
elderly patients, patients with prosthetic valves, and hospitalized patients. In all 
four groups, the initial presentation may be limited to fever and malaise, making 
diagnosis difficult. Unlike endocarditis caused by less virulent pathogens, 
Staphylococcus aureus endocarditis is characterized by a rapid onset, high fever, 
frequent involvement of normal cardiac valves, and the absence of physical 
stigmata of the disease on initial presentation. In one study, 13 percent of febrile 
intravenous drug users evaluated in an emergency room had endocarditis, and the 
diagnosis could not have been predicted on the basis of available clinical or 
laboratory data. In cases of endocarditis related to intravenous drug use, the 
disease is frequently right-sided, the patients are young, the mortality rate is low, 
and the majority of patients do not have antecedent valvular disease. The prognosis 
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is worse for intravenous drug users who have advanced disease associated with 
human immunodeficiency virus (HIV) infection than it is for those without HIV 
infection. Staphylococcus aureus is one of the most common pathogens in 
nosocomial and prosthetic-valve endocarditis, and intravascular catheters are the 
most frequent source of bacterial inoculation. The mortality rate for nosocomial 
endocarditis, regardless of the pathogen, is 40 to 56 percent, and the rate is even 
higher when the pathogen is Stapylococcus aureus. In many of these cases, the 
diagnosis is obscured by other conditions or the administration of antibiotics. 
Prosthetic-valve endocarditis, especially in the early postoperative period, is often 
Fulminant and is characterized by the formation of myocardial abscesses and the 
development of valvular insufficiency. Fang et al noted a 43 percent incidence of 
endocarditis in patients with prosthetic valves who had nosocomial bacteremia. 
The most common pathogen was Staphylococcus aureus. 32 
Pneumonia 
Although   Staphylococcus aureus pneumonia is nosocomial, it accounts for 
a small proportion of community-acquired pneumonia especially in certain groups 
like diabetic patients. Although 15-30% of adults are nasal carriers of 
Staphylococcus aureus, resulting pneumonia is rare. Ventilator associated 
pneumonia   especially due to MRSA   are rising in incidence (17%) and pose 
unique challenge in their prevention and treatment. Risk factors for development 
of MRSA include nasal carriage, poor antibiotic therapy, prolonged mechanical 
ventilation, poor infection control measures, head injury /coma and viral 
infections.35 
Urinary tract infection 
Staphylococcus aureus is a relatively infrequent urinary tract isolate in the 
general population. In a multicenter, community-based study conducted in Great 
Britain, Staphylococcus aureus accounted for only 0.5% of isolates. A similar 
laboratory-based study conducted in France found that Staphylococcus aureus 
accounted for only 1.3% of isolates from urine specimens submitted from the 
community. Prior studies suggest that isolation of Staphylococcus aureus from the 
urine is often secondary to staphylococcal bacteremia originating at another site 
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(e.g., in cases of endocarditis) 36,71 Isolation of Staphylococcus aureus from urine 
samples in the absence of bacteremia is therefore often considered to represent 
colonization. 37 
In specific patient populations, however, Staphylococcus aureus can be an 
important primary urinary pathogen. For example, MRSA urinary tract infection 
occurs in both endemic and epidemic fashion among patients undergoing urologic 
surgical procedures. MRSA bacteriuria occurs among long-term care patients as 
well, and it is significantly associated with urinary catheterization and antibiotic 
use.38 It is problematic to define the exact role of Staphylococcus aureus as a cause 
of symptomatic urinary tract infection, as opposed to colonization, in this 
population. Long-term care patients have a high frequency of asymptomatic 
bacteriuria. There is evidence to suggest that the majority of febrile episodes in 
long-term care patients with bacteriuria are not, in fact, due to urinary tract 
infection. 
Traditionally MRSA has been considered   a major   nosocomial pathogen.   
In this decade it has been observed   to be emerging in the community as well. The 
first case   of community acquired   MRSA infection in the United States was 
reported in 1980.43 More widespread identification of community acquired 
methicillin resistant Staphylococcus aureus in the United States began in the 
year1990, following   the report   of community acquired methicillin resistant 
Staphylococcus aureus infections among four children. Patients with community 
acquired methicillin resistant Staphylococcus aureus have often lacked the risked 
factors known for patients with hospital associated MRSA, which include recent 
hospitalization, dialysis, nursing home residence and other co-morbid conditions 
such as diabetes, chronic renal failure, chronic pulmonary disease which bring 
them into contact with health care setting. Community acquired methicillin 
resistant Staphylococcus aureus has also been found to be composed of more 
diverse clonal groups than hospital   acquired methicillin resistant Staphylococcus 
aureus. Earlier only 2% of Staphylococcus aureus   clinical isolates had panton 
valentine leukocidin (PVL) gene. The PVL gene has been virtually found in all 
isolates   of community   acquired methicillin resistant Staphylococcus aureus 
causing epidemics   worldwide.44   New strains of Staphylococcus aureus 
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displaying unique combinations of virulence factors and resistant traits have been 
associated with high morbidity and mortality in the community.  
The substantial increase in community acquired methicillin resistant   
Staphylococcus aureus    infection has increased the challenge of selecting 
empirical antimicrobial treatment in outpatient settings. Previous studies have 
reported that in the United States the prevalence of community acquired 
methicillin   resistant Staphylococcus aureus infection varies from 76 % among 
MRSA skin and soft tissue infection isolates in Alaska65 to 12 % of all MRSA 
infection in Minnesota.66 In other studies community acquired methicillin   
resistant Staphylococcus aureus infection   rate ranges from 30.2 to   45%. 43 In a 
study done in India the total   Incidence of MRSA was 51.6 % in burns and ortho 
wards, out of which hospital acquired   methicillin resistant Staphylococcus aureus   
was contributed by 87.3 % and community acquired methicillin   resistant 
Staphylococcus aureus infection was   12.7 %. 1 
Overall, community acquired methicillin   resistant Staphylococcus aureus 
infection   was unlikely to result in prolonged hospitalization. Most of these 
infections responded to wound care and out patient oral antimicrobial therapy. 
Both hospital acquired Staphylococcus aureus and community acquired methicillin   
resistant Staphylococcus aureus infection are highly virulent strains capable of 
Clonal dissemination and have the ability to cause epidemics of furunculosis and 
other skin and soft tissue infections.  Nevertheless non- health care MRSA are now 
responsible for majority of community onset MRSA in USA. Furthermore despite 
their designation as community MRSA strains, these strains are no longer 
restricted to that setting since community onset MRSA strains have now been 
found in association with nosocomial infection. Irrespective of the characteristics 
of population or the setting, the community onset MRSA carrying the SCC mec 
type IV and V element poses a serious threat and in all likelihood will continue to 
emerge as a major health concern.55,56 
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Infections Common In Coagualse Negative Staphylococcus 
Bacteremia:  
The blood stream infection (BSI) caused by CONS is mostly nosocomial but 
CONS have also been isolated from about 8% of patients with community acquired 
blood stream infection.45 The number of cases of nosocomial bacteremia due to 
coagulase negative staphylococci has been estimated at 50,000-120,000 per year in 
the United States. In the NNIS data sheet, these bacteremia constitute 8% of all 
nosocomial infections, but it is very important to differentiate contaminants from 
infection especially blood samples.  Bacteremia   due to CONS is nosocomial in 
origin   and is related to presence of an indwelling foreign body. According to 
several surveys CONS is the most prevalent pathogen isolated from blood   
accounting for 15-30% of blood cultures isolates.40,45,59,60 Staphylococcus 
epidermidis is the most frequently isolated species among CONS has been 
implicated in a variety of infections including blood stream infection 39mostly 
associated with intravascular catheters and other prosthetic devices. 
Staphylococcus haemolyticus, the second most commonly isolated species.9A 
variety of other CONS have also been implicated in BSI including Staphylococcus 
capitis, Staphylococcus homins, Staphylococcus lugdenesis, Staphylococcus 
saprophyticus, Staphylococcus schleiferi, Staphylococcus simulans and 
Staphylococcus warneri. The proportion of cons among blood culture isolates seem 
to   decrease with increasing age.40 Crude mortality in patients with CONS blood 
stream infection ranges from 14 to 31%40 
Catheter related infections 
Staphylococcus epidermidis is responsible for 50-70% of these infections. 
Coagulase negative Staphylococcal bacteremia is seldom life threatening 
especially if treated promptly, although frank sepsis syndrome may occur 
especially in immunocompromised patients. Coagulase Negative Staphylococci 
may produce exit -site infections, tunnel infections, infected thromobophlebitis and 
other complications such as infective endocarditis and abscesses. Staphylococcus 
lugdenensis has also been implicated in catheter related infections, arthritis and 
prosthetic joint infections.41 
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Central nervous system shunt infections 
Coagulase Negative Staphylococci are the most common bacteria isolated 
from cerebrospinal fluid shunt infections {48% to 67% of isolates) and 
Staphylococcus epidermidis is the predominant species.3, 5  
Endocarditis 
Native valve endocardits due to Coagulase Negative staphylococci is 
relatively rare and is characterized by a relatively indolent clinical course. 
Staphylococcus epidermidis is the most common species. Other species such as 
Staphylococcus warneri and Staphylococcus lugdunensis are also implicated in 
infections of prosthetic valves   in 40-50% of cases. 3, 5 
Urinary tract infections  
  Urinary tract infections due to Staphylococcus saprophyticus    mainly 
affect   young female outpatients47. It is implicated in 10-20% of UTI in females. It 
is 2nd most common cause of UTI in women between ages 17-27 years. 
Nosocomial urinary tract infections due to other   staphylococci mainly 
Staphylococcus epidermidis   occurs equally in men and women, especially in 
those with urinary catheters.3, 5 
Surgical site infection (SSI) 
 The most common organism causing SSI is Staphylococcus aureus (20%) 
and SSI caused by CONS is 14% and Enterococci contribute to 12%29. CONS are 
ranked second according to NNIS data. Most infections are mainly caused by 
patients own endogenous skin flora 
Other common infections that can occur by CONS are bone and joint 
infections, opportunistic infections and wound infections, mainly by 
Staphylococcus haemolyticus. 
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Identification of staphylococcus aureus and other coagulase 
negative staphylococci 
Collection and handling of specimens 
Proper collection, transport and processing are essential in the correct 
diagnosis and interpretation of any bacterial culture result. Clinical materials 
collected from infected sites should be transported to the laboratory without delay 
to prevent drying, maintain the proper environment and minimize growth of 
contaminating organisms 4, 5  
Stuart’s and Amie’s gel transport media can be used for transport of 
samples. There are studies which say that Stuart’s media is better than   Amie’s gel 
media106 
Microscopic examination and culture: 
Cultures of clinical specimens should be performed as soon as possible to 
minimize changes in the microbial composition from what was originally present. 
Direct microscopic examination of normally sterile fluids may provide a rapid 
presumptive report of gram-positive cocci resembling   staphylococci. Isolation of 
staphylococci from primary clinical specimens like pus, wound swabs, CSF, joint 
aspirates, urine samples, blood cultures etc is usually performed using blood agar 
and Maconkey agar, following an incubation period of 18-24 hour in air at 35-
37◦C. Colonies are usually 1-3 mm in diameter, circular, smooth and raised with 
butyrous consistency. Colonies of most species and sub species cannot be 
differentiated from one another on this medium. Pigmentation is best seen on milk 
agar. Screening for the presence of Staphylococcus aureus   in mixed cultures   
such as nasal swabs   is often performed using mannitol salt agar. Staphylococcus 
aureus ferments mannitol resulting in a change in the colour of the medium from 
pink to yellow.4, 5, 11 
 28
Identification of Staphylococcus aureus 
 
Staphylococcus aureus is distinguished from other Staphylococcal species 
on the basis of their yellow or cream pigmentation of colonies and positive results 
of Coagulase, Mannitol-fermentation, and deoxyribonuclease tests.13 
Staphylococcus aureus is often beta hemolytic on blood agar, Staphylococcus 
epidermidis is non hemolytic. Staphylococcus aureus are facultative anaerobes that 
grow by aerobic respiration or by fermentation that yields principally lactic acid. 
 
They are separated from streptococci by the catalase test. Streptococci are 
catalase negative. This test is performed by adding 3% hydrogen peroxide to a 
colony on slide or a tube. Catalase positive cultures produce oxygen and bubble at 
once. Staphylococcus aureus is differentiated from CONS by the coagulase test. 
Free Coagulase clots plasma (preferably rabbit’s) in the absence of calcium. 
 
Coagulase test:  
 
Staphylococcus aureus produce a coagulase ,a prothrombin  activator and 
convert  fibrinogen to fibrin. Most  strains produce  both free coagulase  which 
react  in the tube coagulase  test and bound Coagulase (clumping factor ) which 
react  in the slide coagulase test.Asmall minority of strains   form only  the one  or 
the other  type of coagulase.Lesser  common species namely  Staphylococcus  
schleiferi and Staphylococcus lugdunensis may also give slide  coagulase 
positive4,5.  
Fermentation of mannitol is another important feature of Staphylococcus 
aureus.  Mannitol salt agar (MSA) or variations of this medium have been 
extensively used as a screening medium for Staphylococcus aureus especially 
MRSA .The reported sensitivity of this media has varied widely 51.The addition of 
lipovitellin to detect lipase production   may markedly increase the sensitivity of 
MSA 
The most prevalent staphylococcal species and subspecies in human 
infections are Staphylococcus aureus, Staphylococcus epidermidis Staphylococcus 
haemolyticus and Staphylococcus saprophyticus followed by Staphylococcus 
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hominis Staphylococcus warneri, Staphylococcus lugdunensis, Staphylococcus 
schleiferi Staphylococcus capitis and Staphylococcus simulans. 9  Staphylococcus 
haemoltyicus has been documented as a cause of primary and nosocomial 
bacteremia, wound and soft tissues infections, urinary tract infection and 
nosocomial pediatric and neonatal infections. Staphylococcus hominis found on 
skin and occasionally isolated from infections as a low-grade pathogen-causing 
catheter related sepsis in immunocompromised host. Staphylococcus simulans 
found on skin and in urethra of healthy women. This organism has been isolated as 
a cause of septicemia, osteomyelitis, native valve endocarditis, and septic arthritis 
following open reduction of fractured fibula, vertebral osteomyelitis and prosthetic 
joint infections. Staphylococcus cohini was first described in 1975 and 
1991.Staphylococcus cohini subspecies cohini has been isolated in humans. 
Though normal flora of the skin it is an emergent opportunistic agent having been 
reported as a cause of community acquired pneumonia, septic arthritis, catheter 
related sepsis, chorioaminontis and neonatal sepsis with meningitis. The above 
staphylococcal species and sub species can be distinguished on the basis of 
minimal key characters. Speciation of CONS is done according to method followed 
by Kloos and S chleifer.77 The test includes fermentation of sucrose, trehalose, 
maltose, lactose, xylose, mannose, fructose and mannitol. Other test like VP test 
for looking for production of acetoin, urease test, polymyxin B sensitivity, 
ornithine decarboxylase test, nitrate reduction, phosphatase test on 
phenophathalein diphosphate agar and susceptibility to novobiocin. 
Mechanisms of Resistance to Antimicrobial Agents  
Penicillin is inactivated by beta-lactamase, a serine protease that hydrolyzes 
the beta-lactam ring. Less than 5 percent of isolates remain sensitive to 
penicillin16. In a study, incidence of Methicillin resistant Staphylococcus aureus 
was 31%, and almost all strains (99.6%) were resistant to penicillin, 93.6% were 
resistant to Ampicillin in addition to 63.2% resistance towards gentamicin, 
cotrimoxazole, erythromycin and cefotaxime.59 Some other studies quote 
100%resistance to penicillin in addition to   97% resistance to cotrimoxazole and 
93.3%resistant to chloramphenicol.67      
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Resistance to methicillin   confers resistance to all penicillinase-resistant 
penicillins and cephalosporins. This high level of resistance requires the presence 
of the mec gene that encodes penicillin-binding protein 2a. The mec genes 
probably originated from a different species of staphylococci. Although many 
methicillin-resistant strains appear to be descendants of a limited number of 
clones, some appear to be multiclonal in origin, suggesting the horizontal transfer 
of mec DNA. Other staphylococcal genes, including bla (for beta-lactamase) and 
fem (for factors essential for methicillin resistance), affect the expression of 
resistance. The expression of resistance to methicillin is often heterogeneous, and 
the percentage of a bacterial population that expresses the resistance phenotype 
varies according to the environmental conditions. The first methicillin resistant 
staphylococci was   first reported   in the United Kingdom in 1961,shortly after 
methicillin was introduced into clinical practice.6, 7 Seven years later after the 
resistant strain had become widespread in Japan, Europe, and Australia, the first 
case   of MRSA was described in the United states in1968. Antimicrobial-
sensitivity testing has been modified to enhance the detection of the resistance 
phenotype. . Confirmation of sensitivity by the agar or broth-dilution method is 
recommended. Other methods for detecting MRSA include, use of oxacillin 
resistance screen agar, determination of mic to oxacillin, detection of penicillin 
binding protein( PBP2a) by using latex agglutination, detection of Mec Agene and 
Fem A/B gene etc by PCR. 
Resistance   to Vancomycin 
Resistance to vancomycin has been reported in clinical isolates of 
Staphylococcus haemolyticus, a coagulase-negative species. The enterococcal 
plasmid-bearing gene for resistance to vancomycin has been transferred by 
conjugation to Staphylococcus aureus in vitro. Three types of resistance to 
vancomycin have been described since1997 in Staphylococci.  
i. Staphylococcus aureus   with intermediate level resistance to 
vancomycin (VISA) 
ii. Staphylococcus aureus with hetero resistance to vancomycin 
(hVISA) 
iii. Vancomycin resistant Staphylococcus aureus (VRSA) 
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The main mechanism of vancomycin resistance for VISA and VRSA   are 
currently under investigation. 
Four recent case reports (one from Japan and three from the United States) 
have documented the isolation of clinical strains with intermediate sensitivity to 
vancomycin (minimal inhibitory concentration, 8-16 µg per milliliter). 3The 
mechanism of resistance in these isolates is not known but is not due to the van 
genes present in enterococci. Both increased cell-wall synthesis and alterations in 
the cell wall that prevent vancomycin from reaching sites of cell-wall synthesis 
have been suggested as mechanisms. Screening for strains of Staphylococcus 
aureus with intermediate sensitivities to glycopeptides including vancomycin 
(glycopeptide-intermediate strains) can be performed with the use of brain–heart 
infusion agar plates supplemented with 6 µg of vancomycin per milliliter. The 
incidence of vancomycin  intermediate staphylococcus aureus and  vancomycin 
resistant Staphylococcus aureus has been increasing  in various  parts of the 
world.101,102 Vancomycin-resistant Staphylococcus aureus strains are likely to pose 
a major therapeutic challenge in the future.  
Resistance to macrolides, lincosamide and streptogramin (MLS) 3 
Erythromycin resistant staphylococci often have cross resistance to 
macrolides, lincosamides and streptogramin type B antibiotics (designated MLS 
resistant) The different types of MLS antibiotics bind to 50 s ribosomal subunit at 
overlapping binding sites and binding interferes with transpeptidation and 
translocation needed for peptide chain elongation. Clinical isolates of constitutive 
MLS resistant staphylococci   are continuing to increase in   frequency and this 
trend   may be a reflection of increased clinical use of clindamycin. The incidence 
of erythromycin resistance   is about 63% in MRSA and 34.4% in MSSA.57In 
another study incidence was about 25.3%58. Erythromycin   resistance through the 
erythromycin   ribose methylase gene (erm gene) and initially susceptible to 
clindamycin can potentially   develop resistance to   clindamycin during therapy. 
To detect inducible clindamycin resistance 15µg erythromycin and 2µg 
clindamycin disk   were placed 15 -20 mm apart for Staphylococcus aureus and 20-
26mm for coagulase negative staphylococcus strains. Staphylococcus aureus 25923 
was used as control for these tests. In the double disk diffusion test, if there is 
 32
inducible clindamycin resistance, the erythromycin   will diffuse through out the 
agar, and resistance to lincosamide will be induced resulting in flattening or 
blunting of the lincosamide zone of inhibition adjacent to the erythromycin disc 
giving the shape of D to the zone. The isolates resistant to both erythromycin and 
clindamycin were defined as showing constitutive MLSb resistance and those that 
showed the flattening between the two disks was defined as having inducible 
MLSb resistance. The   rate   of induced clindamycin   resistance in MRSA   
isolates vary   widely from 2- 8% in Houston TX to 94% in Chicago. There are 
studies quoting 30% induced clindamycin resistance.94 So nowadays   many 
laboratories perform double disk diffusion   test (Dtest) to determine   whether 
Clindamycin susceptible MRSA   habours inducible resistance.  
 The inducible macrolide and streptogramin resistance phenotype involves 
erythromycin cross-resistance to other 14-16 membered ring macrolides and 
streptogramin type B, but not the lincosamides.3 
Resistance to tetracycline 
This is wide spread among staphylococcal species and ranks, and   along 
with Beta lactam and MLS resistance is one of the most frequent antibiotic 
resistance found in natural populations of staphylococci. The incidence of 
Tetracycline resistance in MRSA ranges from 33.5 to 63.1% and   in MSSA it 
ranges from 22.4 to 27.5%.3,4,107  There are two mechanisms of tetracycline 
resistance; the most common one is the energy dependent pumping (efflux) of 
tetracycline and doxycycline from the cells, so that levels of these antibiotics   are 
reduced below the required, to inhibit the ribosome.  The efflux protein is most 
often coded by the inducible    gene tetK which is located on class I plasmids of 
the pT181 family. The second mechanism, one that is controlled by gene Tet M 
involves   ribosome protection such that protein synthesis is unaffected by the 
presence of   tetracycline, doxycycline or minocycline.3     
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Resistance to aminoglycosides 
In studies done on antibiotic susceptibility of MRSA, the incidence of 
resistance to amikacin   is about    52.6%59 and resistance to gentamicin ranged 
between 96.7% to 100% 60,61,62,63 
There are three major mechanisms for aminoglycoside resistance3 
i. The Change in ribosomal proteins as a consequence of certain 
mutations in their structural genes such that ribosomes can no longer 
bind streptomycin. 
ii. Energization and permeability of the cell membrane.  
iii. Modification of aminoglycosides by aminoglycoside - modifying 
enzymes so that antibiotics are no longer capable of binding to 
ribosome. The genes encoding these enzymes are located on 
plasmids (eg gentamycin resistance plasmids) or on the 
chromosomes  
Resistance to trimethoprim 
 It is mediated by alteration in the expression of the intrinsic   chromosomal 
dfr gene possibly resulting in the overproduction of the native dihydrofolate 
reductase (DHFR) or   a reduced affinity of native DHFR   for trimethoprim or by 
acquisition   of a second chromosomal or plasmid dfr gene that encodes a 
trimethoprim resistant DHFR capable of rescuing the reduction step leading to 
tetrahydrolate in the presence of Trimethoprim.The incidence of resistance to 
cotrimoxazole ranges between   8.5% and  70%59,60 
Resistance to fluroquinolones 
The incidence of resistance to ciprofloxacin in MRSA ranges from 86.1% to 
92.8%59 
There are three mechanisms by which resistance is developed3  
i. Mutation in the gyrA encoding the DNA gyrase subunit A 
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ii. A second mechanism involves mutations in the chromosomal gene 
Nora or its regulatory region that encodes a membrane efflux protein 
for hydrophilic fluroquinolones and other unrelated antibiotics  
            Iii    A third mechanism   involves mutation in chromosomal gene grlA that       
encodes the A subunit of DNA topoisomerase IV  
 
Detection of Methicillin resistance by different methods 
Disc diffusion methods49, 50,86 
                                 Disc diffusion methods remain the mostly widely used in 
routine clinical laboratories. Traditionally oxacillin has been tested and results are 
representative of all beta lactam agents. Cefoxitin has been recently investigated as 
an alternative agent for detection of resistance by disc diffusion and all studies 
indicate that the test is more reliable than those with oxacillin disc. 
Mannitol salt agar medium (MSA) 49, 50 
  MSA   was developed in 1945 as a selective medium for isolation of 
pathogenic staphylococci. It is regarded as a valuable medium   for isolation of 
Staphylococcus aureus from water, milk, skin, respiratory tract secretion and nose. 
Since 1985, MSA has been studied with regards to its suitability as a medium for 
susceptibility testing.  In a particular study, disc diffusion tests using 1µg of 
oxacillin on MSA   was found to be an excellent screening method to detect 
oxacillin resistance in Staphylococcus aureus, giving a sensitivity of 100% and a 
specificity of 97.6%51.The agar screen test on MSA was highly sensitive (98.1%) 
and specificity was 95%. 51  
Lipovitellin salt mannitol agar50 
 This medium has also been evaluated for disc diffusion tests with 1µg of 
oxacillin. A zone diameter of <13mm was interpreted as evidence for oxacillin 
resistance. This medium has a sensitivity of 100 % and a specificity of 70%. 
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Dilution methods 
Agar dilution: 50 – Test on Muller Hinton Agar with 2% Sodium chloride 
and an inoculum of 104 cfu/ml    will distinguish most resistant from susceptible 
strains. This method requires incubation for 24 hours at 33-35 ºC. These are among 
the NCCLS recommendations for increasing the chance of detection of resistance  
by agar and  broth dilution.In this method an excelling MIC    <2 mg/L indicates 
that the strain is susceptible and an MIC > 2mg/L   indicates that the strain is 
resistant. 
Broth microdilution.50 
This method recommended by NCCLS requires the use of Mueller Hinton 
broth with 2% sodium chloride, an inoculum of 5*105 cfu/ml and subjected to 
incubation at 33-35 C for 24 hours. 
E test method 50 
The E test method using Mueller Hinton agar with 2%sodum chloride, an 
inoculum density equivalent to 0.5- 1.0 McFarland standard, an application of 
inoculum with a swab and incubation at 35◦ C for 24 hours. 
Agar screening method 52 
The method recommended by NCCLS requires suspending the test 
organisms   to a density of 0.5 Macfarland standard and inoculating into Mueller 
Hinton agar containing 4% sodium chloride and 6mg/l oxacillin with a spot or 
streak of the organisms. Plates are incubated at 35◦ C or less for 24 hours and any 
growth other than a single colony indicative of resistance.  This method has been 
recommended for screening colonies isolated on routine media   and for 
confirmation of suspect resistance seen in disc diffusion tests. 
Latex agglutination 50, 53 
 A rapid slide agglutination based on detection of PBP2a is commercially 
available. This method involves   extraction of PBP2a from a suspension of 
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colonies and demonstration of agglutination with latex particles coated with 
monoclonal antibody to PBP2a. There are studies done and   test was proved to be 
highly sensitive and specific.89, 90 
Molecular methods50 
Detection of genes specific for resistance, that is, the MecA gene for 
methicillin resistance of Staphylococcus aureus is done by Polymerase Chain 
Reaction (PCR). As of now this method is the Gold standard for the detection of 
MRSA. This has become a gold standard   for comparison of sensitivity and 
specificity of other test. Some investigators include PCR detection of second gene 
such as fem A, Fem B and a specific marker gene nuc specific for Staphylococcus 
aureus, and multiplex PCR can be performed   to detect different genes associated 
with resistance to different antibiotics groups 54 
Bacteriophage typing11 
 Bacteriophage typing is essential in the detection of sources  of nursery 
epidemics  and other outbreaks  and for  controlling such events.It is based on the 
susceptibility  of  Staphylococcus aureus  to infection by various  bacterial  viruses 
(bacteriophages). The set of basic phages used for Staphylococcus aureus    are   
Group 1 - 29, 52, 52A, 79, 80 
Group2 – 3A, 3B, 3C, 55, 71 
Group 3- 6, 7, 42E, 47, 53,54,75,77, 83A 
Group 4- 42D 
Miscellaneous -81,187 
Phage typing has been used to type isolates of Staphylococcus aureus for over 45 years. 
Various molecular methods have been described for typing isolates of MRSA. They 
include ribotyping, random amplification of polymorphic DNA by PCR insertion 
sequence profiling, PCR-restriction fragment length polymorphism (PCR-RFLP) and, 
notably, pulsed-field gel electrophoresis (PFGE) 109 
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Treatment of Staphylococcus aureus Infection  
Penicillin remains the drug of choice if the isolate is sensitive to it. Semi 
synthetic penicillin (nafcillin or cloxacillin) is indicated for beta-Lactamases–
producing strains. In patients with histories penicillin allergy, a cephalosporin such 
as cefazolin or cephalothin is an acceptable alternative. Changes in pattern of 
antimicrobial susceptibility of Staphylococcus aureus have been reported world 
wide especially in developing countries, making antimicrobial agents increasingly, 
less effective in treating bacterial infections. Over the past twelve years there have 
been dramatic changes   in the susceptibility of Staphylococcus aureus in both 
hospitals acquired and community acquired   infections.  The hospital acquired 
MRSA(HAMRSA) is more multi drug resistant compared to community acquired 
MRSA (CAMRSA). The older β lactams, penicillin and Ampicillin are ineffective 
against more than 80% of strains and resistance to many of the non β lactam agents 
such as tetracycline, erythromycin and Clindamycin has gradually reached 
alarming levels by the year 1990.  MRSA and MSSA strains can easily spread from 
infected patients to medical staff that often becomes transient carriers. An 
important component of therapy, especially when cutaneous community acquired 
methicillin resistant Staphylococcus aureus infection presents as abscess, is the 
incision and drainage. In addition to this, systemic antibiotic therapy can be given. 
Topical applications such as mupirocin can be given for decolonization of 
intranasal MRSA and other carriers.  CAMRSA are more susceptible to other 
antibiotics, such as ciprofloxacin and Clindamycin. Studies     show   that   there is 
usually a high prevalence of resistance to erythromycin (61%- 93%). 64, 65 
Trimethoprim- sulphamethoxazole can be given as monotherapy or in 
combination with rifampicin to treat community acquired methicillin resistant 
Staphylococcus aureus especially those of cutaneous orgin ones. Clindamycin is 
another drug which can be given in combination with rifampicin is also useful. But 
disadvantage is that it can cause pseudomembranous colitis.In addition increasing 
Clindamycin resistance is emerging recently. Community acquired methicillin 
resistant   strains that are Erythromycin resistant through the erythromycin ribose 
methylase gene (erm gene) and initially susceptible to Clindamycin can potentially 
develop resistance to Clindamycin during therapy. The rate of induced 
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Clindamycin resistance in MRSA isolates vary   widely from 2- 8% in Houston TX 
to 94% in Chicago.So nowadays many laboratories perform double disk diffusion 
test to determine   whether Clindamycin susceptible MRSA harbors inducible 
resistance. MRSAs may be susceptible to tetracycline .The susceptibility to MRSA 
especially community   acquired methicillin resistant to fluroquinolones is 
variable. Newer quinolones like gatifloxacin and moxifloxacin if used in 
combination with other antibiotics may not susceptible to development of 
resistance by community acquired methicillin resistant staphylococcus aureus. . 
Serious infections, vancomycin I/V is recommended, however subsequent culture 
confirmation of MRSA is suggested, as β lactams such as cefazolin and 
semisysthetic penicillanase resistant penicillin such as oxacilin, naficillin are 
rapidly more bacteriocidal and more efficacious than vancomycin against MSSA.   
The   MRSA are usually   also resistant to other β lactams, so infections with 
MRSA are life threatening especially in immunocompromised often becoming 
difficult to eradicate. Vancomycin is the drug of choice for methicillin-resistant 
isolates. Patients unable to tolerate vancomycin have been treated with 
fluoroquinolones, trimethoprim–sulfamethoxazole, clindamycin, or minocycline. 
Each of these drugs has been effective in cases that require bactericidal therapy. 
They are not as effective as vancomycin, however, either because they have less 
antistaphylococcal activity or because resistance develops during therapy. 
Quinolones with enhanced antistaphylococcal activity have recently become 
available, but their use may also be limited by the development of resistance 
during therapy. A number of potentially active drugs are under investigation, 
including quinupristin–dalfopristin, a new carbapenem, and a new family of 
antimicrobial drugs, oxzolidinones.  Several new staphylococcal agents have 
recently been developed   that provide additional therapeutic alternatives for 
patients   with MRSA such as linezolid, quinpristin-dalphopristin, teicoplanin and 
Tigecyline .In addition emerging agents that are currently being evaluated and may 
be useful for treating MRSA include ceftobiprole, dalbavancin, oritavancin and 
telavancin.  Antimicrobial combinations have been used to increase bactericidal 
activity or to prevent the development of antimicrobial resistance. The 
combination of beta -lactams and aminoglycosides increases bacterial killing in 
vitro and in animal models of endocarditis. In a clinical trial comparing a single 
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drug with combination therapy for the treatment of endocarditis, combination 
therapy resulted in more rapid clearance of bacteria from the bloodstream, but the 
clinical outcome was the same with the two approaches. Many clinicians use an 
aminoglycoside, when possible, for the first few days of therapy.  
Rifampicin is another potent antistaphylococcal drug, but resistance 
invariably develops if it is used alone. Although the efficacy of rifampin as an 
adjunctive drug in patients with life-threatening infections remains controversial, it 
is recommended in combination with gentamicin and vancomycin or nafcillin for 
the treatment of prosthetic-valve endocarditis. Rifampicin has also been combined 
with quinolones in an effort to prevent the development of resistance  
The duration of therapy for invasive, life-threatening infections, including 
those that cause endocarditis, osteomyelitis, or arthritis, is four weeks or longer. 
The appropriate duration of treatment for bacteremia originating from a removable 
focus of infection, such as an intravascular catheter, is controversial. A two-week 
period of therapy has been recommended for infections considered to pose a low 
risk of complications (those caused by catheterization in non-immuno 
compromised patients without valvular abnormalities, with prompt removal of the 
catheter, rapid clearance of bacteremia, and no evidence of metastatic infection). 
However, a meta-analysis concluded that, despite the reportedly low complication 
rates, the available data do not justify short-course therapy in such patients. There 
is also concern that endocarditis has been under- diagnosed because of a reliance 
on clinical criteria. Despite some promising studies, tests for serum anti–teichoic 
acid antibodies to help identify patients at risk for complications have not proved 
useful. 
Prevention of Staphylococcal Disease 
The revised guidelines for control of MRSA include isolation of patient in a 
separate cubicle, limiting the movement and transport of the patient. Hand   
washing with soaps containing disinfectants like chlorhexidine with alcohol or 
triclosan containing products, and use of disposable gloves and wearing mask and 
gown during procedures is effective.  No   equipment   or items should be shared 
with other patients and instruments to be reused should be thoroughly cleansed 
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with soap and water and autoclaved before reuse, mattresses used by the patients   
should be treated with strong sunlight to ensure disinfection and all mattresses 
should be covered with rexin sheets that can be disinfected. 
The use of topical agents to eliminate staphylococcal colonization in high-
risk groups, such as patients undergoing hemodialysis or surgery, has been shown 
to reduce the incidence of subsequent infections. Mupirocin, a topical 
antistaphylococcal agent that inhibits RNA and protein synthesis, eliminates nasal 
colonization in carriers and can reduce the incidence of wound infections. 
Although the development of resistance to mupirocin to date has been limited, 
prolonged use of the drug has been associated with resistance.  
A capsular polysaccharide–protein conjugate antistaphylococcal vaccine has 
produced improved phagocytosis in vitro and improved survival in experimental 
models of staphylococcal infection, including endocarditis. Balaban et al 
demonstrated that immunization with RNAIII-activating protein, an agr-encoded 
protein involved in regulating the expression of staphylococcal exoproteins, is 
protective in an experimental model of cutaneous infection.68 Other potential 
approaches involve the development of multicomponent vaccines incorporating 
proteins identified as having a role in the pathogenesis of staphylococcal disease.  
At present, prevention of the spread of infection relies on the application of 
appropriate principles of infection control. These approaches have been effective 
in reducing the nosocomial spread of staphylococcal infection.  
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MATERIALS & METHODS 
 
 The study was carried out from May 2006 to August 2007 at PSG Hospitals, 
Coimbatore. Clinical samples such as sputum, blood, pus, CVP tips, tracheal 
aspirates, urine etc were processed for isolation of Staphylococci. A Gram stain 
was performed initially, and then the samples were inoculated on two 10% sheep 
blood agar (one for aerobic and the other for anaerobic), MacConkey and nutrient 
agar plates. Blood samples sent in brain heart infusion broths were incubated for 
18 hours and then sub cultured onto blood, MacConkey and chocolate agar plates.  
These plates were then incubated at 37o C for 24 to 48 hours. All the suspected 
colonies were Gram stained and subjected to various biochemical tests to identify 
and characterize them.  
 
  Medical records for the source patients were searched for demographic 
information, history of prior hospitalization, presence of  major conditions,  (like 
Diabetes mellitus) renal dysfunctions, post surgical status, malignancy, organ 
transplant, and trauma or burn injury. Antibiotic exposure within the preceding 
year was recorded. Follow up studies were done for 100 patients from whom 
MRSA was isolated, as to what antibiotic   was given   and they were followed up 
till their culture was sterile. 
 
Tests to differentiate members of Micrococcaceae family from the other 
Gram-positive cocci. 
Catalase test4 
A suspected colony was taken with a wooden rod and transferred onto slide 
and tube containing 3% hydrogen peroxide and looked for effervescence. 
 
Tests for Differentiation of Staphylococci from Micrococci. 
Modified Hugh and Leifsons O/f test4 
 
The culture under test was inoculated into two tubes of O/f dextrose 
medium by stabbing down their whole length with a long wire loop.  One tube was 
covered with a layer of sterile liquid paraffin of atleast 2.5 cm deep after 
inoculating the culture into it and   both tubes were incubated at 37°C for five 
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days. Staphylococci produce acid by fermentation throughout the depth of medium 
both in the anaerobic tube sealed with paraffin oil and in the aerobic tube. 
Micrococci fail to produce acid in both the tubes or produce acid in the aerobic 
tube only. 
    
Susceptibility to Bacitracin 4 
 
  A suspension of bacterium was spread over a plate of Mueller Hinton agar.  
A disk containing 0.04 units of bacitracin was placed on it and the plates were 
incubated overnight.  Most staphylococci grew upto the disc   or showed a   zone 
of inhibition of less than 10mm in diameter 
 
Susceptibility to furazolidine4 
 
This test was performed as a disk susceptibility procedure .The organism to 
be tested was grown in peptone water and matched with 0.5 Mac Farland turbidity 
standard. The organism was spread    on a blood agar plate using a swab. 
Aseptically a furazolidone disk containing 100 µg was placed   in the center of the 
inoculated area and gently the disk was stamped so that it adheres to the agar 
surface. The plate   was incubated at 35 ºC in an ambient  -air incubator for 18-24 
hours and then examined. 
 
Distinguishing staphylococcus   from micrococcus11 
 
Property Staphylococcus Micrococcus 
Anerobic growth + _ 
Carbohydrate utilization Fermentative Oxidative 
Catalase + + 
Oxidase _ + 
Sensitivity to Bacitracin R S 
Sensitivity to furazolidine S R 
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Differentiation of Staphylococcus aureus from other Staphylococci  
 Coagulase test4 
Slide coagulase test 
 
This test detects clumping factor, which is present in Staphylococcus 
aureus. It is absent in most other Staphylococci. The reagent used was rabbit 
plasma. Rabbit plasma was obtained by centrifuging blood to which 0.1% ethylene 
diamine tetra acetic acid was added as anticoagulant .The plasma was stored in 
small portions at 20ºC and the in use plasma was stored at 4ºC and was brought to 
room temperature before use. 
 
  Clumping factor can be detected by standard slide test performed   by 
making a heavy suspension   of cells in saline and stirring the mixture to a 
homogeneous composition and then adding a drop of rabbit plasma .The mixture   
should be examined for clumping factor within about 10 seconds. Similar 
suspensions of positive and negative control strains were made and examined.  
 
Tube coagulase test4 
 
A 1in 6 dilution of plasma in saline was prepared and 1 ml volume of 
diluted plasma was placed in small tubes. A colony under test was emulsified    in 
the diluted plasma.  Positive and Negative controls were included. The tubes   were 
incubated at 37º C and were examined for clot formation after four hours and if 
negative, were left at room temperature for the next 12-16 hours and were re-
examined for presence of a clot.  
 
Deoxyribonuclease test (DNase test) 4 
 
DNA agar plates were dried of all the moisture and the plates were divided 
into sections   and strains   under test   were touched with an inoculating loop and 
spot inoculation was done. Positive and negative controls were used. The plates 
were incubated at 37º C for 24 hours and then they were flooded with   a few 
milliliter of 1mol/litre of 3.6% Hydrochloric acid to precipitate unhydrolyzed 
DNA.After few minutes the plates were examined. Spot cultures that were 
surrounded by clear cloudy zone comparable in width to zone around the positive 
control were considered as positive. 
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Phosphatase test 
 
Phenolphthalein diphosphate agar plates were taken and the strains were 
inoculated and incubated at 37ºC   for 18-24 hours. The next day the growth was 
exposed to ammonia. The cultures, which turned bright pink, were taken as 
positive for the production of phosphatase. 
 
Mannitol fermentation 
 
The test organism   was inoculated on mannitol salt agar. The medium 
consisted of 1% mannitol, 7.5%sodium chloride, phenol red and peptones. The 
plates were incubated at 37 ºC for 18-24 hours and then examined. 
 
Coagulase negative staphylococci 
Criteria for Inclusion 
 
Type of specimen Inclusion Criteria 
Urine 
105 CFU/ml and absence of other recognized bacterial 
pathogensa 
Nonurinary 
Growth 1+ (few)b and single bacterial morphotype of 
CONS and absence of other recognized bacterial 
pathogensa 
Growth greater than 2+ (moderate) b and absence of other 
recognized bacterial pathogensa 
 
a Defined as Staphylococcus aureus, beta-hemolytic streptococci, and all aerobic 
gram-negative bacilli.  
b Defined based on the study12 
 
Identification of CONS 
Ornithine decarboxylase test4 
Preparation of medium 
 
Peptone, yeast extract and glucose were dissolved   in one litre of distilled 
water and the ph was adjusted to 6.7. 10ml of bromocresol purple 0.2% solution 
was added and L ornithine hydrochloride was added to get the final concentration 
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of 0.5%. Volumes of 3ml was taken in each tubes and sterilized by autoclaving. 
Once the broth was cool, the test organism was inoculated into it and the tube was 
overlayered with 5mm of sterile mineral oil. The tubes were incubated at 37ºC for 
24-48 hours. Violet coloration of medium indicates production of decarboxylase by 
the organism. 
 
Urease test4 
 
    Urea medium was streaked with test culture and they were incubated at 37º C 
for 18-24 hours and then examined. Urease producing organisms turned the 
medium dark pink. Phenol red was the indicator used. 
 
Acetoin production test (Voges prauskauer test) 4   
         
Glucose phosphate broth was inoculated with the test organism and 
incubated at 37º C for 24 to 48 hours and then 5%alpha naphthol in ethanol and 
40%potassium hydroxide were added in the ratio of 3:1 and the broth is shaken 
vigorously for 30 seconds   and aerated and then examined. Reddening of 
supernatant within 5- 10 minutes was indicative of acid production in the glucose 
phosphate broth. 
 
Carbohydrate fermentaion    
 
Sugar broth consisted of one of the sugars (1%) (Glucose, trehalose, 
mannitol, sucrose, maltose, fructose  and mannose) 5oogms filtered and added into 
sterile nutrient broth and andrade’s indicator was added into the broths. The test 
organisms were inoculated into the broths and the broths were incubated at 37 ºC 
for 18-24 hours.  
 
Novobiocin sensitivity 
 
         All the urine samples which grew staphylococci   were tested for novobiocin 
sensitivity. All the strains were lawn cultured on muller hinton agar plates and 5µg 
novobiocin disc was included in the disc diffusion test for antibiotic sensitivity. 
Staphylococcus saprophyticus shows no zone or zone less than 10 mm in diameter. 
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Susceptibility to polymyxin B 
 
This test was done on muller hinton agar along with novobiocin   
susceptibility. A suspension of the organism equivalent to 0.5 Mc Farland turbidity 
standard was prepared in peptone water and swabbed on a mullerhinton agar plate.  
A polymyxin B disk (300 units) was aseptically placed   in the center of the plate 
and the plates were incubated at 37º C for 18-24 hours and then examined. 
 
 Indentification of staphylococci was done by referring the table I, II & III 
Determination of Antibiotic susceptibility of staphylococcus aureus and 
clinically relevant coagualse negative staphylococci93 
 
Antimicrobial susceptibility testing was done on Muller Hinton agar and their 
susceptibilities to antimicrobials including Oxacillin (1µg), Cefoxitin (30µg), 
Trimethoprim- Sulfamethoxazole (1.25/23.75µg), Tetracycline (30µg), Linezolid (30µg), 
Erythromycin (15µg), Clindamycin (2µg), Vancomycin (30µg), Teicoplanin (30µg), 
Chloramphenicol (30µg), Ciprofloxacin (5µg), Penicillin (10units), Amikacin 
(30µg),Gentamycin (! 0µg), Rifampicin (5µg), Muprocin (5µg), Fusidic acid (10µg) were 
recorded.  
 
Determination of induced clindamycin resistance (Dtest) 15 
 
The double disc diffusion test (D test) was performed on all MRSA isolates 
whose antimicrobial susceptibility pattern were clindamycin susceptible and 
erythromycin resistant. To detect inducible clindamycin resistance 15µg 
Erythromycin and 2µg Clindamycin disk   were placed 15 -20 mm apart for 
Staphylococcus aureus and 20-26mm for coagulase negative staphylococcus 
strains. Staphylococcus aureus 25923 was used as control for these tests and the 
plates were incubated at 37 ◦C for 18 to 24 hours .In the double disk diffusion test, 
if there is inducible Clindamycin resistance, the Erythromycin  will diffuse through 
out the agar, and resistance to Lincosamide will be induced resulting in flattening 
or blunting of the Lincosamide zone of inhibition adjacent to the Erythromycin 
disc giving the shape of D to the zone. 
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Identification of hospital acquired methicillin resistant Staphylococcus aureus 
 
MRSA isolates were designated as HAMRSA if the source patient had any 
of following risk factors: 1) a history of hospitalization, 2) residence in a long term 
case facility, (eg nursing home), 3) dialysis or surgery within one year prior to date 
of specimen collection, 4) growth of MRSA after 48 hr or more after admission to 
a hospital, 5) presence of a permanent indwelling catheter or percutaneous device 
at the time of culture or prior to this study. If none of above risk factors were 
present them isolate was considered as CAMRSA.48 
  
Detection of Methicillin resistant staphylococcus aureus 
 
All the 610 Staphylococcus aureus isolated phenotypically by different 
biochemical tests, were subjected to susceptibility testing using Oxacillin(1µg), 
Cefoxitin (30ug)(Himedia) disc diffusion method for detection of methicillin 
resistance. Out of 610, a total of 250 isolates were subjected to other phenotypic 
detection methods such as Oxacillin resistance agar screen, detection of MIC of 
Oxacillin(Himedia)  by agar dilution method and using mannitol salt agar for 
detecting methicillin resistance instead of muller hinton agar.Of the 250 isolates of 
Staphylococcus aureus,100 were selected from those isolates which were sensitive 
to   both Oxacillin and Cefoxitin disk,130  from those isolates which were resistant 
to Oxacillin and Cefoxitin disk by disk diffusion method and 20 were selected 
from those which were resistant to Oxacillin but sensitive to Cefoxitin. 
 
Methods for detection of MRSA  
Oxacillin Disc diffusion method: 11, 13, 49, 50 
 
A sterile swab was dipped in Staphylococcus suspension (Mc farland 
standard 0.5) and was plated on Muller Hinton agar and mannitol salt agar using 
oxacillin 1µg and plates were incubated at 37o C for 24 hour.  The zone of 
inhibition was documented in millimetres. If the zone diameter is ≤10 mm, then 
the isolate is resistant to Oxacillin.If the zone diameter is ≥13mm, then the isolate 
is said to be sensitive 
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Cefoxitin Disc Diffusion method11, 13, 49, 50 
 
A sterile swab was dipped in staphylococcus suspension (Mc farland 
standard 0.5) and was plated on Muller Hinton agar and mannitol salt agar using 
Cefoxitin  30µg and plates were incubated at 37o C for 18-24 hour.  The zone of 
inhibition was documented in millimetres. If the zone diameter≥22mm, then the 
isolate is said to be sensitive, and if the zone diameter is ≤21mm, then the isolate 
is said to be resistant to Cefoxitin.  
Agar screen test: 52 Oxacillin resistance screen agar using 6mg of Oxacillin /litre 
was used for detection of MRSA. This method was recommended for screening 
colonies isolated on routine culture media and for confirmation of suspect 
resistance seen on disc diffusion test. The test organism was grown in peptone 
water and the density was compared to the density of a 0.5 Mcfarland standard and 
then the test organism (10µl) was spot inoculated on MH agar (containing 4% 
sodium chloride and 6mg / l Oxacillin). Plates were then incubated at 35o C for 24 
hours. The next day the plates were examined for growth of the organisms. Aniline 
blue was the dye used in the medium.  
Interpretation 
Growth of > 1 colony = MRSA 
No growth                = MSSA 
 
Dilution methods 
Agar dilution method49, 50 
About 18-20 ml of Muller hinton agar medium was prepared in test tubes 
and allowed to cool in 50º C waterbaths. Serial dilutions of oxacillin powder was 
prepared in sterile water First 10mg of oxacillin was weighed and diluted in 10ml 
of sterile water. Seven sterile test testtubes were taken and serial dilutions of stock 
solutions was done and diluted antibiotic solutions were added to cooled broth in 
the ratio of 1ml   of antibiotic solution to 19ml of the medium. After adding the 
antibiotic agent in the medium, it was mixed well and poured into Petri dishes. So 
the dilutions were ranged from 0.5µg/ml to 32µg/ml. A control plate   containing 
the test medium without the antibiotic was prepared for each series of dilution. 
After the plates were set, they were dried at 37 ºC. Fresh inoculum of an actively 
growing organism was taken and the turbidity was adjusted to 1 Mac Farland 
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standard. The dried plates were taken and divided and marked .A platinum loop 
calibrated to deliver 0.001ml of the inoculum was used to spot inoculate the 
culture. A quality control organism was also included. Inoculated plates were left 
undisturbed until the spots of inoculum dried .The plates were then inverted and 
incubated at 37 ºC for 16-18 hours and then examined for growth. 
 
Molecular detection of MRSA by PCR 
Steps 
 DNA extraction 
 PCR amplification of the extracted DNA 
 Gel documentation of the amplified product 
 All the isolates were inoculated into semisolid agar medium and stocked. 
 
Bacterial isolates 
 
 About 55 phenotypically determined Staphylococcus aureus (MRSA and 
MSSA) were randomly selected from the 250 selected for phenotypic detection of 
methicillin resistant Staphylococcus aureus  .Ten from Diabetic patients, five from 
burns infections, Five from skin infections, ten from surgical site wound 
infections, six from osteomyelitis cases, fivefrom pneumonia cases, three from 
UTI, two control strains (MRSA and oxford Staphylococcus aureus) nine cases 
which were resistant by oxacillin disk diffusion but were sensitive by cefoxitin 
disk diffusion methods were also added in our study. 
 
Materials required for extraction 
Chemicals and reagents 
 Equilibrated phenols 
 Chloroform extra pure 
 Isoamyl alcohol 
 10XTBE buffer 
 10 X TAE buffer 
 Sodium chloride M grade 
 Phosphate buffered saline 
 Proteinase K 
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 Sodium dodecyl sulphate 
 Absolute alcohol 
 
DNA Extraction: 69 
 Pure DNA was prepared by growing bacteria in 5ml of Brain heart infusion 
broth for 18 hour.  The grown bacteria were centrifuged at 5000 rpm for 10 
minutes and supernatant discarded.  The sediments were resuspended in lysis 
buffer   and incubated at 37o C for 1 hour.  Equal amount of phenol: chloroform 
mixture was added and vortexed for 30 seconds.  The tubes were centrifuged at 
10,000 rpm at 5min. at room temperature and the top aqueous layer was collected 
into Fresh sterile tube.  To this 60μl of 3M Nacl and 3 volumes of cold absolute 
ethanol was added and the tubes were kept at -20o C overnight for precipitation. 
The tubes were centrifuged at 10000 rpm for 30 minutes at 4o C. 
 
The supernatant was discarded and 200μl of 70% Ethanol was added to 
pellet and centrifuge again at 10,000 for 15 min.  The supernatant was discarded 
and   the pellet   was air-dried. The pellet was dissolved in 0.5ml of T10E Buffer  
 
PCR reaction: 69 
PCR mixture consist of  
 Mec A Primer 
Forward and reverse primers of MecA 
Forward primer -5’AAATCAGATGGTAAAGGTTGGC3’ 
Reverse primer-5’AGTTCTGCAGTACCGGATTTGC3’ 
 Fem A Primer 
Forward primer-5’AAAAAAGCACATAACAAGCG3’ 
Reverse primer-5’GATAAAGAAGAAACGAGCAG3’ 
 d NTP 
 Tag buffer 
 Tag polymerase 
 2 μl of extracted DNA template 
By using 2.5μl of template DNA and 2 µl each of both primers (forward and 
reverse) 2ul each, dNTP-0.8ul, Tag Buffer -2μl and tag polymerase 0.2ul were 
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added and DNA amplification was carried out for forty cycles in 20ul of reaction 
mixture as follows. 
1. Denaturation at 95oC for 45 seconds 
2. Annealing at 55o C for 45 seconds 
3. Extension at 72o C for 1 minute 
4. A final extension at 72o C for 5 minutes 
          The amplified product is now ready for analysis 
 
Analysis of PCR product: 69 
 
 The PCR product was analyzed in 1.5% agarose gel prepared using TAE 
buffer and 0.5ug / ml ethidium bromide.  The molten agarose gel was cast in the 
electrophoresis tank with combs. Once the gel solidified, the comb was removed 
and TAE buffer was added to completely immerse the gel.  10µl of amplified PCR 
product was mixed with 2ul of 0.1 bromophenol blue, (tracking dye) and were 
loaded into the wells.  A DNA ladder of 100 base pairs with tracking dye and 
amplified product of methicillin resistant staphylococcus aureus control strain and 
oxford stain of staphylococcus aureus were loaded in each run. After 1 hour the gel 
was removed and documented in gel documentation system. The MecA gene was 
recognized by presence of 533 bp band and FemA gene was by the presence 132 bp 
band. 
 
Statistical methods used for analysis of observation and results.  
 
Chi square test were used to compare proportions. Percentages were 
calculated where necessary.Sensitivity and Specificity were used to test the 
performance of detection methods of MRSA. 
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RESULTS 
 
 Out of the 24321 samples sent for cultures during the study period, 5919 
samples were culture positive and of these 651(10.9%) isolates were staphylococci. 
Of the 651 Staphylococcus species isolated, 610 were identified as Staphylococcus 
aureus (Fig.1 & Fig.2) and 41 as clinically relevant CONS. Among the 610 
Staphylococcus aureus, 208 were identified as MRSA (34.1%) based on cefoxitin 
resistance and 402 as MSSA based on cefoxitin susceptibility. (Table No.1) Of the 
total MRSA’s, 82% were hospital acquired and 18% were community acquired. 
 
Table No.1Prevalence of Staphylococcus aureus amongst all clinical isolates in 
PSG Hospitals 
 
Total No. of clinical samples during the study period 24321 
Total No. of samples which were culture positive 5919 (24.36%) 
Total No. of Staphylococci amongst all isolates 651 (10.9%) 
Total No. of SA (% among all Staphylococci) 610 (93.7%) 
Total No. of MSSA (% among all S.aureus) 402 (65.9%) 
Total No. of MRSA  (% among all S.aureus) 208 (34.1%) 
Total No. of clinically relevant CONS (% among all 
Staphylococci) 
41 (6.3%) 
 
Distribution of staphylococcus aureus amongst different samples 
Staphylococcus aureus was the predominant single isolate in pus, catheter 
tips and synovial fluid samples. (Table No.2) Maximum number of SA was 
isolated from pus (63%), followed by urine samples (14%), catheter tip(8%) and 
blood (7%).(Fig.3) Staphylococcus aureus were methicillin sensitive in 82% of 
isolates in blood, 67% in pus and 56% in urine, whereas from catheter tips, 85 % 
were methicillin resistant (Table No.2)  
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Table No.2 Prevalence of S.aureus among isolates in various samples 
 
Sample MRSA MSSA Total SA 
Others 
organisms 
Total 
Pus 128(32.48%) 267(67.5%) 395(20.8%) 1503(79.2%) 1898 
Catheter tip 17(85%) 3(15%) 20(11.83%) 149(88.1%) 169 
Urine 30(44.11%) 38(55.88%) 68(3.4%) 1894(96.6%) 1962 
Blood 15(18.07%) 68(81.92%) 83(17.44%) 476(82.56%) 559 
BAL 2(40%) 3(60%) 5(11.1%) 40(88.9%) 45 
Sputum 6(46.15%) 7(53.84%) 13(2.24%) 565(97.7%) 578 
Tracheal aspirate 7(46.7%) 8(53.3%) 15(2.9%) 498(97.26%) 512 
Synovial Fluid 0(0%) 2(100%) 2(50%) 2(50%) 4 
Throat swab 0(0%0 1(100%) 1(3.22%) 30(96.77) 31 
Ear swab 3(37.5%) 5(62.5%) 8(4.9%) 153 161 
Total 208(34.09%) 402(65.9%) 610 5310 5919 
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Fig .3 :   Distribution of MRSA among different samples 
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  Age and sex wise distribution of Staphylococcus aureus among patients: 
 
Patients above 40 years were significantly more affected with MRSA than 
other age groups (p=.0027). Only 1.1% of isolates of Staphylococcus aureus were 
from neonates. (Table 2) The percentage of males affected with MRSA was 
34.22% and the females affected were 33.89%. (Table 3) There was no significant 
difference between MRSA occurrence among males and females. 
 
Table No 3: Age wise distribution of Staphylococcus aureus 
 
Age MRSA No (%) 
 
MSSA No (%) Total (610) 
Neonates 2 (0.9%) 5 /1.24% 7 (1.1%) 
< 14years 15 /7.2% 67 /16.6% 82 (13.4%) 
14-40 years 72/ 34.6% 108 /26.8% 180 (29.5%) 
> 40 years 119 /57% 222/55.2% 341 (56%) 
 
Table No.4: Sex wise distribution of Staphylococcus aureus 
 
Sex MRSA MSSA Total (610) 
Male 128(34.22%) 246(65.8%) 374 (61%) 
Female 
 
80(33.89) 156(66.11%) 236 (39%) 
 
Frequency of MRSA in various infections as compared to other organisms 
 
Among the ICU cases, 17% were contributed by MRSA, rest were 
contributed mainly by Pseudomonas aeroginosa, Acinetobacter baumani, 
Klebsiella pneumonia, Candida and Aspergillus sp. Among all patients with 
infected burns, MRSA was isolated in 16% cases. In most infections MSSA was 
isolated  more  than MRSA, marginally, except in burns, where MRSA was present 
in more percentage of cases.(Table 5)  
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Table No 5: Comparison of frequency of MRSA versus other bacteria in 
various infections: 
 
Infections MSSA  (%) MRSA (%) SA (%) Other bacteria 
(%) 
Burns 4.2 16 20.2 79.8 
Surgical site infection 10.6 3.2 13.8 86 
Diabetic wounds 9 4 13 87 
ICU 20 17 37 63 
VAP 8 9 17 83 
Neonatal infections 6 2 8% 92% 
 
Distribution of Staphylococcus aureus among various infections  
 
Maximum number of Staphylococcus aureus was isolated from surgical site 
infections (34.9%) and diabetic wounds (18.36%). Septicaemias constituted 13.8% 
of all staphylococcus aureus infections. Staphylococcal skin infections such as 
cellulitis, furuncle and Staphylococcal scalded skin syndrome constituted 4.4% of 
infections. MSSA was predominant among most infections except in burns, where 
75% were MRSA. (Table 6, Fig 4) 
 
Table No.6:  Distribution of Staphylococcus aureus among different infections 
 
Diagnosis MRSA MSSA Total SA 
Surgical wound infections  52(24.41%) 161(75.58%) 213 (34.9%) 
Diabetic wounds  49(43.75%) 63(56.25%) 112 (18.36%) 
Burns  21(75%) 7(25%) 28 (4.6%) 
Osteomyelitis/Septic 
arthritis  
19(46.34%) 22(53.65%) 41 (6.7%) 
Cellulitis,furuncle, 
scalded skin syndrome 
9(33%) 18(66%) 27 (4.4%) 
Urinary tract infections  22(37%) 38(63%) 60 (9.8%) 
Septicemia 15(17.9%) 69(82.1%) 84 (13.8%) 
Pneumonia 15(44%) 19(56%) 34 (5.8%) 
CSOM  6(55%) 5(45%)  11(1.8%) 
Total 208(34.1%) 402(65.9%) 610 
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Fig.4: Distribution of Staphylococcus aureus among different infections   (in numbers) 
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Distribution of MRSA among various infections 
 
 
Total number of MRSA isolated was 208. Most Number of cases of MRSA 
was isolated from surgical site infections(25%) followed by diabetic patients 
(23.6%), UTI (11%), burns cases (10%),Osteomyelitis(9%) and skin infections 
(4.3%), Pneumonia cases(7%), CSOM(3%) and Septicemia (7%)(Fig.5)  
 
Staphylococcal skin infections  
           Only 27 cases of classical Staphylococcal skin infections were seen in this 
study among the 610 Staphylococci isolated.  Predominant Staphylococcal skin 
infections were folliculitis and cellulitis. Majority (66%) were Methicillin 
Sensitive. All the MRSA here were community acquired except the lone 
Staphylococcal Scalded Skin syndrome which was hospital acquired. This case of 
toxic epidermolysis grew MSSA initially, but subsequently after prolonged 
hospitalization, MRSA became the predominant isolate. (Table 7, fig 6,7)   
 
Table 7: Distribution of Staphylococcus aureus among different skin  
infections (n=27) 
Skin infections MSSA MRSA Total 
Carbuncle 3 2 5 
Furuncle 2 1 3 
Folliculitis 8 2 10 
Cellulitis 5 3 8 
Staphylococcal 
scalded skin 
syndrome 
0 1 1 
Total 18(66%) 9(33%) 27 
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Fig.5: Distribution of MRSA among different infections 
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Fig. 6: Distribution of Skin infections (in numbers) 
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Antibiogram of Staphylococcus aureus 
 
The antibiotic susceptibility pattern of all the isolates of Staphylococcus aureus are 
depicted in the bar diagram. All the isolates were sensitive to Vancomycin, Linezolid and 
Teicoplanin. Penicillin sensitivity was found to be 22% among MSSA isolates. Most 
MSSA isolates were sensitive to Gentamicin (73%), Erythromycin (84%), Ciprofloxacin 
(72%), Tetracycline (92%) and Amikacin (96%) A significant difference was 
demonstrated between the sensitivity of MRSA and MSSA to Tetracycline, 
Cotrimoxazole, Gentamicin, Amikacin, Erythromycin and Ciprofloxacin. (Table No. 9, 
fig 8)  Such a difference was not observed with Chloramphenicol. Induced resistance to 
Clindamycin was found in39.4% of MRSA isolates, constitutive resistance was found in 
33.7%,D test  was negative in 18.9% and 8% were sensitive to both Clindamycin and 
Erythromycin  . (Fig .9) 
 
 
Table No.9: Antibiotic Sensitivity pattern of Staphylococcus aureus 
Antibiotics MSSA (% S) MRSA (% S) 
P value 
(Significance of difference 
in sensitivity) 
Penicillin 22 0 <0.05(S) 
Tetracycline 92 36 <0.05(S) 
Amikacin 96 40 <0.05(S) 
Erythromycin 84 8 <0.05(S) 
Cotrimoxazole 67 13 <0.05(S) 
Gentamycin 73 8 <0.05(S) 
Ciprofloxacin 72 6 <0.05(S) 
Chloramphenicol 95 92 >0.05(NS) 
Vancomycin 100 100 >0.05(NS) 
Linezolid 100 100 >0.05(NS) 
Teicoplanin 100 100 >0.05(NS) 
Note : S – Significant,   NS- Not Significant 
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Fig 8: Antibiotic Sensitivity pattern of Staphylococcus aureus 
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Detection of inducible resistance to clindamycin in MRSA  
 
The D test was positive in 39% of all MRSA isolates, indicating that they 
exhibited inducible resistance. Only 19% of MRSA showed true sensitivity to 
Clindamycin as the D test was negative in these isolates. Susceptibility to both 
Erythromycin and Clindamycin was seen in 8% of isolates (fig.9). 
 
 
Fig 9: Susceptibility of MRSA isolates to Clindamycin and 
Erythromycin 
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Susceptibility pattern of CAMRSA as compared to that of HAMRSA 
 
A significant difference was demonstrated between the sensitivity of CA 
MRSA and HAMRSA to ciprofloxacin. (p=0.008). More numbers of CAMRSA 
were found to be sensitive to antibiotics like Amikacin, Erythromycin, 
Cotrimoxazole, Tetracycline and Chloramphenicol   than HAMRSA, but this fact 
was not statistically significant. 
 
Table 9: Antibiogram of CAMRSA as compared to that of HAMRSA 
Antibiotics 
 
CAMRSA 
(%) 
Sensitive 
HAMRSA (%) 
Sensitive 
P value 
(significance of 
difference in 
sensitivity) 
Ciprofloxacin 16 0 0.008(S) 
Erythromycin 3.2 0 0.3368 
Amikacin 41.93 24 0.128 
Cotrimoxazole 20 7.4 0.1560 
Tetracycline 20.8 11.29 0.3024 
Chloramphenicol 10.34 7.4 0.690 
     Note: S-Significant 
 
Coagulase negative staphylococci  
 
All the 41 CONS isolated were from patients with history of indwelling 
catheters/ on artificial valves or from patients who were on ventilators and other 
support systems. Staphylococcus epidermidis 24(58.5%) was found to be the 
predominant species among all CONS, followed by Staphylococcus haemolyticus 6 
(14.6%), Staphylococcus cohini 3 (9.7%), Staphylococcus hominis 4(7%), 
Staphylococcus saprophyticus 3(7%) and Staphylococcus simulans 1(2.4%). 
Distribution of Clinically   relevant CONS   among various samples and the their 
percentage  is  depicted  in table No10 and fig.10. 
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Table 10: Species Distribution of clinically relevant CONS 
Species Pus Blood Urine Total 
S. epidermidis  20 4 0 24 
S. haemolyticus 3 3 0 6 
S. saprophyticus  0 0 3 3 
S.cohini 0 4 0 4 
S. hominis 2 1 0 3 
S. simulans 1 0 0 1 
          Total  26 12 3 41 
 
Antibiotic sensitivity pattern of CONS 
Majority of clinically relevant CONS identified were resistant to cloxacillin. 
All the strains were sensitive to Vancomycin, Linezolid and Teicoplanin. 
MSCONS were more sensitive as compared to MRCONS. (Table 10,fig 11) 
Table No. 11: camparison of antibiotic susceptibility pattern of                     
mscons and mrcons 
 
Antibiotics MSCONS (% S) MRCONS (% S) 
Vancomycin 100 100 
Linezolid 100 100 
Teicoplanin 100 100 
Chloramphenicol 96 91 
Ciprofloxacin 78 22 
Cotrimoxazole 55 20 
Amikacin 97 69 
Gentamycin 72 17 
Erythromycin 65 17 
Tetracycline 79 75 
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Fig.10 Distribution of various species of CONS 
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Fig.11 :Antibiogram of Coagulase Negative Staphylococci 
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Detection of MRSA by different phenotypic methods 
 Out of 610 Staphylococcus aureus isolates, 382 (62.6%) were identified as 
MSSA based on cefoxitin and oxacillin susceptibility. A total of 208 (34.09%) 
isolates were identified as MRSA based on cefoxitin and oxacillin resistance. The 
remaining 20(3.2%) isolates were resistant to oxacillin but sensitive to cefoxitin. 
These isolates showing a discrepant result were subjected to further phenotypic 
and genotypic detection methods and were confirmed as MSSA. When cefoxitin 
and oxacillin disc diffusion tests were compared with MIC by agar dilutions tests, 
it was found that, those strains which were  resistant  to oxacillin  and sensitive  to 
cefoxitin  by disk diffusion method  had an MIC of 4-8 µg/ml, while   the isolates 
which  were  sensitive to  both oxacillin and cefoxitin  had an mic of 0.5-2 µg/ml  ( 
<2µg/ml=MSSA). Those isolates that were resistant to both cefoxitin and oxacillin,    
had an mic of > 16µg/ml. Phenotypic detection of MRSA is shown in fig 12 & 
fig.13.  
 
Detection of Methicillin resistance by molecular method and its comparison 
with detection by phenotypic methods. 
Of the 55 isolates tested for detection of methicillin resistance by phenotypic and 
molecular methods, 44 were methicillin resistant by oxacillin disc diffusion and mannitol 
salt agar methods, whereas only 35 were resistant by cefoxitin disc diffusion and PCR 
methods. By Oxacillin disk diffusion method, the Sensitivity for identification of MRSA 
was 100%  and Specificity was only 56%. Therefore the percentage of false positives was 
45%, and that of false negatives was 0%. By Cefoxitin disk diffusion, sensitivity and 
specificity was 100% and percentage of false negatives and false positives were 0%. 
Using Mannitol salt agar instead of muller hinton agar and with the kirby bauer disk 
diffusion method, sensitivity and specificity were 100 amd 56% similiar to oxacillin disk 
diffusion method using muller hinton agar. A detailed result of detection by different 
methods is as follows. Genotypic detection of MRSA is shown in Table 13, fig.14. 
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Table 13: Comparison of detection of MRSA by different methods (n=55) 
 
 
 
Method of  detection MRSA MSSA Sensitivity (%) 
Specificity 
(%) 
Predictive value 
of positive 
test(%) 
Predictive value 
of negative 
test(%) 
Oxacillin disk diffusion 
method 
44 11 100 56 79.5 100 
Cefoxitin disk diffusion 
method 
35 20 100 100 100 100 
Mannitol salt agar (using 1 
mg disk of oxacillin) 
44 11 100 56 79.5 100 
Oxacillin resistance screen 
agar 
40 15 97.5 75 87.5 100 
MIC of oxacillin using agar 
dilution 
37 18 100 90 94.6 100 
PCR- Detection of MecA and 
Fem A gene 
35 20 100 100 100 100 
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By determination of MIC by agar dilution, all the strains that were MSSA by other 
methods had an MIC of <=2µg/ml and they were negative for mecA gene by PCR.  All 
the strains that were MRSA by cefoxitin disk diffusion method had a MIC of >32 µg/ml 
and they were positive for mecA gene. All the isolates that had an MIC of 4- 8 µg/ml 
were MRSA by agar dilution, but they were negative for mecA gene. By agar dilution 
method, sensitivity was 100% and specificity was 90%)  
Methods of detection of MRSA by oxacillin disk diffusion, Cefoxitin disk 
diffusion and PCR, all gave a sensitivity of 100% but only the Cefoxitin disk 
diffusion   and PCR methods were 100% specific. Oxacillin disk diffusion was 
false positive in 45% of cases. 
Follow up of patients from whom MRSA was isolated 
Out of the 208 cases from whom MRSA was isolated, 100 patients were 
followed up,of this 66 patients were treated with Linezolid, 12 with Amikacin, 10 
with Ciprofloxacin and 9 with Chloramphenicol. Among the 66 treated with 
Linezolid, in two patients alone, due to delay in wound healing, the patient was 
subsequently treated with Vancomycin. Doxycycline was given to two patients and 
in one patient alone Doxycycline was given in combination with Vancomycin. In 
all patients, the infections healed without further complication. 
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DISCUSSION 
 
For the past 50 years, Staphylococcus aureus has been a dynamic human pathogen 
that has gained the deepest respects of clinicians. It’s incredible success in causing 
disease involves characteristics associated with host susceptibility (age, chronic disease, 
surgery, presence of invasive devices or impaired immunity), the specific strain (genetics, 
ease of colonization, virulence and antibiotic resistance), epidemiology (carriage, 
transmission) and breaches in infection control measures.70 In this  study  Staphylococci  
constituted   10% of all  isolates  during the study  period and among these, 93.7% were 
Staphylococcus aureus.  
 
Since the first report of healthcare associated methicillin resistant Staphylococcus 
aureus infection in US at the Boston city hospital  in 1961, 6 MRSA has become 
widespread all over the world. In our hospital too, a prevalence of 34% is seen. Its 
incidence in other places in India ranges from 30-70%. 1, 8,57,72,73   Similar pattern has been 
seen worldwide.71             
            
           There was a significant difference between different age groups in prevalence of 
MRSA. Elderly patients were significantly (p =0.0027) more prone for infections with 
MRSA as compared to children and young adults. This might be because elderly are more 
immunocompromised   and are affected by debilitating illnesses like diabetes, more than 
the young people. Staphylococci were an important cause of infection among the 
neonates’ upto the 1980s. However, nowadays an overall predominance of Gram negative 
bacteria is noticed.103,104  In our study also, 92% of the isolates in neonates were Gram 
negative and only 8% were caused by Staphylococcus aureus. Almost half of these were 
MRSA. 
 
      Most cases of MRSA in our hospital were contributed by surgical site wound 
infection (25%). There are many studies in support of the same in India.28, 29 and abroad61 
Extensive use of indwelling devices and breaches in infection control measures are cited 
as important reasons for the  predominance of Staphylococcus in these sites. 29   
 
  Methicillin-resistant Staphylococcus aureus (MRSA) have also been isolated with 
increasing frequency from wound and skin infections that commonly affect the lower 
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extremities of patients with diabetes.25   In our study  MRSA was isolated  from 24% of 
diabetic  patients. Antibiotic resistance is reportedly a growing problem in diabetic foot 
infections.  
 
Burns provide a suitable site for bacterial multiplication. Staphylococcus aureus is 
the most common bacteria isolated from these patients. A direct correlation between the 
length of stay of burn patients and the risk of becoming infected with MRSA was seen in 
this study, as was in other studies also.43 Although in our study only 16% of MRSA was 
seen among burns cases, a slightly higher rate was reported in other studies.(24% - 45%) 
30,31,34,74  In fact among all infections caused by Staphylococcus aureus, burns infection is 
the only one where MRSA (16%) is isolated more than MSSA(4%). 
 
There were only 27 cases of classical Staphylococcus aureus skin infections seen in 
this study, and the predominant infections were folliculitis and cellulitis.  Majority were 
methicillin sensitive. 
 
Pneumonia due to MRSA was contributed by 7.21% as compared to 17% in another 
study. 35  
 
In our ICU, 17% of infections were caused by MRSA. There are studies quoting 
30% of ICU infections being contributed by Staphylococcus aureus, out of which 60% 
were identified as MRSA. 97           
 
        The incidence of hospital acquired infections among all MRSA’s was about 82% in 
our study, and the patients were mostly diabetics (24%) or had surgical wound 
infections(25%).  The incidence of community based MRSA in our study was about 18% 
and most cases were contributed by skin infections such as cellulitis and folliculitis, 
which is similar to other studies.43  The pattern of incidence of community acquired 
MRSA by different studies ranges from 7-12.7% in India1 and 12-44% world 
wide15,64,65,91.   
            The antibiotic sensitivity results showed   all MRSA isolates  to be  significantly 
more multidrug resistant as compared to MSSA isolates.(p=<0.001)  In our study only 
about 40%  of MRSA were sensitive to Amikacin and Tetracycline, and  and less than 
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15% were sensitive to  Cotrimoxazole, Gentamycin, Erythromycin and Ciprofloxacin. 
Chloramphenicol alone showed 92% sensitivity as was MSSA too (95%). Excepting 
some, 59 most studies report similar high resistance to Ciprofloxacin, Gentamycin, 
Erythromycin and Cotrimoxazole.60,61,75,93  
           On the contrary, our MSSA isolates showed more than 65% susceptibility to 
gentamycin, amikacin, erythromycin, cotrimoxaxole and ciprofloxacin. All our isolates 
were sensitive to vancomycin, linezolid and teicoplanin but there are a few  studies 
reporting vancomycin intermediate susceptible(VISA) and resistant 
strains(VRSA).57,76,101,102  A significant proportion of our isolates of MSSA (22%) were  
susceptible to penicillin as compared to only <5% isolates being susceptible in other 
studies. 16 
The incidence of induced Clindamycin resistance among MRSA was 39%. Similiar 
results were obtained from other studies also.15,79,94  A significant difference was 
demonstrated between the sensitivity of CA MRSA and HAMRSA to 
ciprofloxacin. (p=0.008). CAMRSA was found to be more sensitive to antibiotics 
like Amikacin, Erythromycin, Cotrimoxazole, Tetracycline and Chloramphenicol 
than HAMRSA, but this fact was not statistically significant as was seen in many 
other studies also.1,72 
  Our study would be incomplete without mentioning about the Coagulase negative 
Staphylococci. These were previously dismissed as skin contaminants and are now 
emerging as important potential pathogens with an increase in the number of severely   
debilitated patients and increased use of implants in hospitals. CONS is one of the leading 
cause of nosocomial infections, especially in neonates, immunocompromised individuals 
and patients with prosthetic implants.9 More than 30 species of CONS are recognized but 
only a few are commonly incriminated in human infections.  Multi-drug resistant strains 
are also common now. In our study, 41 clinically relevant CONs were isolated and 
speciated. Staphylococcus epidermidis was found to be the predominant species among 
CONS (58.5%). Several other studies also identified Staphylococcus epidermidis as the 
predominant species.14,78,95 Staphylococcus epidermidis was followed by Staphylococcus 
haemolyticus (14.6%), Staphylococcus cohini (10%) Staphylococcus saprophyticus,(7%) 
Staphylococcus hominis, (7%) and Staphylococcus simulans (2.4%). They were all 
isolated from patients who were either on    intravascular devices or on ventilators. 
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Staphylococcus haemolyticus was next in our list. They were isolated from  babies who 
were premature/ ventilator assistance and from cutaneous infections. Staphylococcus 
saprophyticus was isolated from urinary tract infections similar to other studies.47 
Antibiotic sensitivity   pattern showed 100% sensitivity to vancomycin, linezolid and 
teicoplanin. MRCONS were less sensitive to Amikacin (69%), Tetracycline (75%) 
Ciprofloxacin (22%), Cotrimoxazole (20%) Gentamycin and Erythromycin (17%) as  
compared to MSCONS and  the results were similar to other studies.87,96 
Comparison of phenotypic methods of detection of methicillin resistance with the 
Gold Standard 
Among all phenotypic methods   tested for detection  of MRSA, Cefoxitin  disk 
diffusion  had better  sensitivity and specificity as compared to   other methods. Both  
methods of detection, namely, cefoxitin  resistance  and presence  of mecA  gene  by PCR,  
demonstrated  a sensitivity  and specificity  of 100% respectively. This is in agreement  
with other studies, 74,80,81,82,83 where as,  the sensitivity  of oxacillin  disk diffusion  was  
100%  and its specificity  was only 56%. Similiar results were quoted  by Swenson etal in 
their phase 1 study, but there are many other studies  quoting  a higher specificity  for 
detection of methicillin resistance by oxacillin  disk diffusion  testing. 97,98,99,100 
The high  false  Positivity (45%) of oxacillin disk diffusion   could be  due to the  
hyperproduction of beta lactamases  and modification  of Penicillin binding proteins( 
PBP), both  of which  may lead   to phenotypic  expression  of oxacillin  resistance .This 
was corroborated  by the fact that   all the isolates  that were  resistant to  oxacillin, but 
sensitive to   cefoxitin  were negative for  mec A gene  by PCR  and their MIC’s were  
between  4-8µg/ml. Propably these strains   under antibiotic  pressure  may evolve  in to 
fully resistant  isolates  subsequently. These isolates were clinically reported as MSSA, 
and all the patients   infected with these isolates, responded well to antibiotics other than 
Linezolid, Vancomycin and Teicoplanin. This was an added, indirect confirmation that 
the isolates were truly methicillin sensitive. Therefore, MIC of oxacillin should be 
determined for those isolates that show discrepant results between oxacillin and cefoxitin 
disk diffusion methods. They can then be confirmed by mecA gene detection.  
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     Both mannitol salt agar and oxacillin screen agar also showed low specificity for 
detection of MRSA. This is in accordance with other studies,92 however  there are a few 
reports  of better  specificity. 51  
           Cefoxitin as disk diffusion method had better sensitivity and specificity. 
Cefoxitin, a cephamycin, is a potent inducer of the mecA regulatory system than   
are the penicillins. Several groups of investigators have reported that the results of 
Cefoxitin disk diffusion method correlates better with the presence of mecA, than 
the results of disk diffusion   using oxacillin.80, 81,82,83,84,85 Cefoxitin disk diffusion 
testing is now an accepted method for detection of methicillin resistance by an 
increasing number of reference laboratories including CLSI. From our study also, 
we have come to the conclusion that cefoxitin disk diffusion is a better and 
cheaper method for identification of MRSA. Errors in detection of oxacillin 
resistance can have serious adverse clinical consequences. False susceptibility 
results may result in treatment failure and the spread of MRSA, if appropriate 
infection control measures are not applied. Conversely   false resistance may 
increase health care cost following unnecessary isolation precautions and may lead 
to over use of glycopeptides and later VRSA might emerge which will make life 
very difficult for all of us 
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SUMMARY AND CONCLUSION 
 
 Staphylococcus aureus was isolated from 610 out of  5919 positive samples obtained 
from different infections in the study  period . 
 Methicillin resistant Staphylococcus aureus  constituted to  34%(208) out  of 610 
isolates of  Staphylococcus aureus. 
 Elderly patients were significantly more prone for infections with MRSA as compared 
to children and young adults. 
 In our study, only 8% of infections  in neonates  were caused by Staphylococcus 
aureus and almost half of these were MRSA and  rest (92%) of the infections were 
caused by  Gram negative bacilli as reported in many other  studies. 
 Most cases of MRSA in our hospital were contributed by surgical site wound 
infection (25%). 
 Methicillin-resistant Staphylococcus aureus (MRSA) have also been isolated with 
increasing frequency from wound and skin infections in patients with diabetes(24%). 
 Among all infected burns cases,16% were caused by MRSA. 
 In our ICU, 17% of infections were caused by MRSA and the  rest were mainly 
contributed by Pseudomonas aeroginosa,Acinetobacter  species and Candida albicans 
 The incidence of hospital  acquired infections  among all MRSAs  was about 82% in 
our study, and the patients  were mostly  diabetics (24%) or had surgical wound 
infections(25%).  
 The incidence of community based MRSA in our study was about 18% and most 
cases were contributed by skin infections such as cellulites, folliculitis and abscesses. 
 In our study only about 40% of MRSA were sensitive to Amikacin and Tetracycline, 
and  less than 15% were sensitive to  Cotrimoxazole, Gentamycin, Erythromycin and 
Ciprofloxacin. Chloramphenicol alone showed 92% sensitivity as was MSSA too 
(95%). 
 In contrast with other studies, 22% of MSSA isolates were sensitive to Penicillin. 
 The  incidence of  induced Clindamycin resistance (Dtest positive) among MRSA was 
39%. 
 CAMRSA was found  to be more sensitive to antibiotics like Amikacin, 
Erythromycin, Cotrimoxazole, Tetracycline and Chloramphenicol than 
HAMRSA, but this fact was  not statistically significant. 
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 In our study, 41 clinically relevant CONs were isolated and speciated. Staphylococcus 
epidermidis was found to be the predominant species among CONS (58.5%). 
Staphylococcus epidermidis was followed by Staphylococcus haemolyticus (14.6%), 
Staphylococcus cohini (10%) Staphylococcus saprophyticus,(7%) Staphylococcus 
hominis,(7%) and Staphylococcus simulans (2.4%). 
 Among  all phenotypic  methods   tested for detection  of MRSA, Cefoxitin  disk 
diffusion  had better  sensitivity and specificity  compared to   other 
methods.Cefoxitin  ,a Cephamycin  ,is a potent inducer of mecA regulatory  system  
than are the penicillins. 
 All the isolates  that were  resistant to  oxacillin, but sensitive to   cefoxitin  were 
negative for  mec A gene  by PCR  and their MIC’s were  between  4-8µg/ml 
 Therefore, MIC  of oxacillin  should be determined  for the isolates that show  
discrepant results between oxacillin and  cefoxitin disk diffusion methods. They can 
then be confirmed by  mecA gene  detection. 
 Cefoxitin as disk diffusion method had better sensitivity and specificity. 
Cefoxitin, a cephamycin, is a potent inducer of the mecA regulatory system 
than   are the penicillins 
 Cefoxitin disk diffusion testing is now an accepted method for detection of 
methicillin resistance by an increasing number of reference laboratories 
including CLSI. 
 We have come to the conclusion that cefoxitin disk diffusion is a better and 
cheaper method for identification of MRSA and errors in detection of oxacillin 
resistance can have serious adverse clinical consequences. 
 False susceptibility results may result in treatment failure and the spread of 
MRSA, if appropriate infection control measures are not applied.  
 Conversely   false resistance may increase health care cost following 
unnecessary isolation precautions and may lead to over use of glycopeptides 
and later VRSA might emerge.  
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ANNEXURE 
1.    Blood Agar (BA) 
Sterile defibrinated sheep blood              7 ml 
Nutrient Agar (melted)     100 ml 
 
Pour about 7 ml of melted Nutrient Agar, as a base, in to sterile Petri dishes and 
allow setting. This forms a thin base for pouring in the blood agar.  Add sterile 
defibrinated sheep blood  (5.7 %) to Nutrient Agar, the latter should be cooled to about 
45-50o C before blood is added. Mix well and pour about 15 ml of blood agar over the 
base in each Petri dish.  Human blood is not recommended for the preparation of 
blood agar. 
Alternatively blood agar may be made with no agar base.  
Use 
 It serves as an enriched medium and a differential medium for hemolytic 
organisms. Most common pathogens grow on it. 
 
2    Carbohydrate Fermentation Media  
 Prepare sugar solutions as described below for different groups of organisms and 
dispense in 3-4 ml quantities in to test tubes (12 x 100 mm). Introduce   Durham’s tubes 
into glucose broth for the detection of gas production. Autoclave at 115o C for 10 
minutes. Disaccharides like lactose and sucrose are better filtered and added to sterile 
basal medium. 
 
3.    Decarboxylase Test Medium  
Basal medium 
 Peptone             5.0 gm 
 Beef extract       5.0 gm 
 Bromcresol purple  0.01 gm 
            Cresol red  (0.2 %) 2.5 ml 
Glucose  0.5 gm 
Pyridoxal  5.0 mg 
Distilled water  1000 ml  
Mix all the ingredients and adjust pH to 6.0. 
Amino acids. 
            L-lysine           
 L-arginine     
 L-ornithine     
     Add to make a final concentration of 1 % each of above. 
  The basal medium is divided into four equal portions, one of which is distributed 
in to tubes (1 ml amounts) without the addition of any amino acid. These tubes of basal 
medium are used as controls. To one of the remaining portions of basal medium add L-
lysine to the second portion add L-arginine and to the last add L-ornithine to get final 
concentrations of one percent each. Distribute these also in one- ml amounts. If DL 
amino acids are used they should be incorporated in to the media in 2 percent 
concentration, since the microorganisms apparently are only active against the L forms.  
Sterilize by autoclaving at 115oC for 10 minutes. 
 
4.Glucose Phosphate Broth or MR-VP medium    
Dipotassium phosphate 5 .0 gm  
Protease peptone  5.0 gm 
Glucose   5.0 gm 
Distilled water   1000 ml 
     Suspend ingredients in distilled water and heat slightly to dissolve them Sterilize the 
tube for 118o  C for 15 minutes. 
 
5. MacConkey Agar (MA) 
 
Peptone  2.0 gm 
Sodium Chloride 0.5 gm 
 
Bile salt  0.5 gm 
Lactose  1.0 gm 
Agar   1.5 gm 
Distilled water  100 ml 
 
Dissolve the ingredients except lactose in distilled water by heating. Adjust pH to 7.6. 
Add 1 ml of 1% neutral red solution to every 100 ml of medium with lactose. Sterilize by 
autoclaving at 121 o C for 15 minutes        
 
Use 
This is a partially selective and a differential medium used for the differentiation of 
lactose fermenting enteric bacteria. 
Note: 
MacConkey Agar for exclusive use in faces cultures, may be prepared with bile salts 
No.3 (Difco) a purified product at a concentration of 0.15 %. Incorporation of this 
purified bile salt will suppress the growth of enterococci and to some extend commensal 
coliform bacteria a well. 
 
6. Mannitol Salt Agar 
 
Beef extract   0.1 gm 
Protease peptone No.3 1.0 gm 
Sodium chloride   7.5 gm 
Mannitol   1.0 gm 
Agar    1.5 gm 
Phenol red   0.0025 gm 
Distilled water   100 ml 
 
Mix the ingredients well in distilled water. Sterilize by autoclaving at 121o C for 15 
minutes. Pour into sterile Petri dishes. 
 
 
 
Use 
This medium is recommended for the selective isolation of Staphylococcus aureus since 
most other bacteria are inhibited by high salt concentration. Colonies of Staphylococcus 
aureus are surrounded by a yellow halo indicating mannitol fermentation. 
 
  7. Milk Agar 
     Fresh milk        100 ml 
     Nutrient Agar containing 3 % agar   200 ml 
  
Boil milk and cool so that the cream layer forms. Remove this completely. This step is 
repeated two to three times .mix with agar and sterilize by autoclaving at 121 oc for 
minutes. Pour as plates or slopes 
 
 
9.MUELLER-HINTON AGAR (M.H.A) 
 
Beef extract                     2.gm 
  Peptone                          7.5gm 
Starch                              1.5gm 
Agar                               17.0gm 
Distilled water               1000ml 
     Dissolve the ingredients in one liter of distilled water .Mix thoroughly. Heat with    
frequent agitation and boil for one minute. Adjust Ph to 7.4+_0.2. Sterilize by 
autoclaving .Do not over heat 
 
10. Nutrient Agar  (NA) 
     Agar powder 1.5 to 1.8 gm 
     Nutrient Broth    !00 ml 
 
 Mix the agar in nutrient broth and heat to dissolve. When cool adjust the pH to 7.5 
– 7.6. Sterilize by autoclaving Pour as plates or slopes. To make deeps, reduce agar 
concentration to 0.5 %. 
Use 
 This is used as a base for many media. Only non-fastidious organisms will grow on this. 
 
 
11.  UREA AGAR CHRISTENSENS 
Urea solutions 
Sodium chloride  5.0 gm 
Dextrose   1.0 gm  
Tryptcase   1.0 gm 
Monopot, phosphate                2.0 gm 
Urea    20.0 gm 
Distilled water   100 ml 
Phenol Red 1% solution (in alcohol) 1.2 ml 
  
UREA AGAR BASE 
 Agar   1.5 gm 
Distilled water                        90 ml 
 
Dissolve the ingredients for the solution in distilled water and adjust pH to 6.8. Then add 
Phenol Red. Sterilize by filtration. Keep this stock solution in the cooler. 
 Dissolve the agar in distilled water. As sterilized by autoclaving. Cool to 45o C 
and add 10 ml of urea solution. Dispense in 3-4 ml quantities in 12 x 100 mm test tubes. 
Allow it to solidify to form a small but and a long slant. 
 
 
12.CARBOHYDRATE FERMENTATION 
 
Test procedure for aerobes 
 Inoculate lightly from a young culture from agar slant or broth. Incubate at 37o C for one 
to five days.  
Reading 
Positive test is shown by acid production (yellow if bromithymol blue indicator is used 
and pink if Andrade’s indicator is used) and or gas inside the Durham tube. 
Eg: E.coli produces acid and gas in glucose; S. typhi acid only. 
 
13.CATALASE TEST 
 
1.Emulsify part of a colony in saline on a clean slide  
2. Add a drop of 3 % Hydrogen peroxide. 
 
Reading positive test is indicated by the appearance of “gas bubbles”.  E.g. Staphylococci 
Note: 
Growth from a blood agar should not be tested  as it might give false positive reaction 
because of the RBCs. 
Include a known positive control always. 
 
 
